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ABSTRACT
Characterization of Insulin Sensitivity and the Plasma Lipidome in Periparturient Dairy Cows.
Sina Saed Samii
During the transition from gestation to lactation, dairy cows experience negative energy balance
due to an increased demand for energy to support milk production coupled with inadequate energy
intake. Energy deficit during the peripartum is associated with the development of insulin
resistance which contributes to adipose tissue lipolysis. In turn, elevated free fatty acids (FFA) in
circulation increase triacylglycerol (TAG) deposition in liver. This metabolic impairment is known
to cause postpartum metabolic diseases including fatty liver and ketosis. Consequently,
postpartum metabolic disease can lead to reduced milk production in early lactation, impaired
reproductive performance, and increased culling rates. Moreover, cows with enhanced prepartum
adiposity are at greater risk for postpartum metabolic disease, relative to lean animals. Therefore,
our first objective was to evaluate the effect of adiposity on insulin and glucose tolerance in lean
and overweight dairy cows during the transition from gestation to lactation. We also wanted to
compare these direct measurements with several indirect measurements, including the commonly
utilized revised quantitative insulin sensitivity check index (RQUICKI). For our second objective
we wanted to identify novel biomarkers for the progression of postpartum metabolic disease in
periparturient dairy cows. To achieve this objective, we utilized a contemporary mass
spectrometry-based lipidomics approach and a bioinformatics workflow. We demonstrate (1) that
excess prepartum adiposity does not influence postpartum systemic insulin sensitivity, (2)
surrogate indices for insulin sensitivity do not correlate with direction measurements, and (3)
biomarkers for metabolic disease include several phosphatidylcholines.
fatty liver, metabolic health, periparturient dairy cow
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CHAPTER 1
INTRODUCTION
Dairy cows transitioning from gestation to lactation develop metabolic adaptations to
support fetal growth and milk production during the peripartum. Specifically, the peripartal cow
will become progressively resistant to insulin as lactation approaches, as a means to shift nutrients
away from adipose and skeletal muscle tissues and towards the mammary gland for the production
of milk (Bell, 1995). This homeorhetic adaptation is accompanied by enhanced lipolysis and
circulating free fatty acids (FFA). Elevated circulating FFA predispose cows to postpartum
metabolic disease risk including ketosis, fatty liver, inflammation, and oxidative stress (Mulligan
and Doherty, 2008). A predisposing factor that increases metabolic disease risk in peripartal cows
is overfeeding of energy and body fat accretion (Dann et al., 2006). In turn, overweight dairy cows
exhibit greater body weight loss during the peripartum relative to lean cows (Rico et al., 2015).
Nutritional approaches are needed to improve metabolic health in peripartal cows with varying
adiposity. Better understanding the underpinning mechanisms of insulin resistance during the
transition period can potentially help nutritionists and farmers improve the metabolic health and
performance of dairy cows.
Reduced systemic insulin and glucose tolerance in monogastrics is associated with
enhanced adiposity (Ross et al., 2001; Hayashi et al., 2008). It has been reported that the greater
magnitude of adiposity in overweight transition dairy cows may predispose these animals to
enhanced insulin resistance and adipose tissue lipolysis, thus contributing to increased disease risk
(Rico et al., 2015; Bossaert et al., 2008). Therefore, we aimed to evaluate the link between
adiposity and glucose responsiveness to insulin in lean and overweight peripartal cows using direct
and indirect methodologies to measure systemic insulin sensitivity. For direct measurements, the
glucose tolerance test (GTT) and insulin tolerance test (ITT) can be employed (Defronzo et al.,
1

1979; McCann and Reimers, 1985; De Koster and Opsomer, 2013). For indirect assessment, the
revised quantitative insulin sensitivity check index (RQUICKI) has been commonly utilized to
evaluate insulin sensitivity in dairy cows (Kerestes et al., 2009); however, discrepancies between
RQUICKI and direct approaches have been documented (Holtenius and Holtenius, 2007; De
Koster et al., 2016; Mann et al., 2016). Thus, our second objective was to compare direct with
indirect measurements of insulin sensitivity in peripartal dairy cows with contrasting adiposity.
Monitoring circulating FFA and β-hydroxybutyrate (BHBA) is a common dairy industry
practice to diagnose metabolic disease. The main limitations of FFA and BHBA testing are the
inability to detect metabolic disease before onset. Lipidomics and metabolomics are systems
biology approaches that have the potential to identify novel predictive biomarkers for the
development of metabolic disease (Kenéz et al., 2016). Several studies have utilized a
metabolomics approach to diagnose periparturient diseases using milk, blood, and rumen fluid
collected during the peripartum (Klein et al., 2012; Saleem et al., 2012; Li et al., 2014). However,
the characterization of the comprehensive lipidome in peripartal dairy cows relative to changes in
FFA, BHBA, and liver lipid accumulation is limited. Therefore, our third objective was to
characterize changes in the plasma lipidome of peripartal dairy cows receiving a common total
mixed ration (TMR) and relate these changes to the disease state of the animal. Our main
hypothesis was that the plasma lipidome of the dairy cow is highly dynamic during the peripartum
and changes in association with the progression of metabolic disease. Our targeted focus was on
phosphatidylcholine (PC) and phosphatidylethanolamine (PE) because of their role on hepatic
lipoprotein secretion and liver lipid accumulation. To test our hypothesis, we utilized liquid
chromatography and time-of-flight mass spectrometry. We then applied a bioinformatics approach
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to analyze our large data set. Our goal was to identify novel biomarkers for metabolic disease
which can be targeted by future nutritional interventions.
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CHAPTER 2
LITERATURE REVIEW
Energy Metabolism in Peripartal Dairy Cattle
The transition period is defined as three weeks before to three weeks after parturition, and
represents a vital period that can negatively impact dairy cow health and productivity as well as
producer profits (Grummer, 1995; Drackley, 1999). Regulation of energy metabolism during the
peripartum involves homeorhetic adaptations facilitated by changes in endocrine status.
Homeorhetic adaptations are defined as the coordinated shifts in body tissue metabolism to support
gestation and lactation (Bauman and Currie, 1980). These metabolic modifications involve
fluctuations in hormone supply and action. In brief, growth hormone (GH) increases during the
peripartum. Growth hormone increases adipose tissue lipolysis and reduces glucose uptake by
inhibiting insulin sensitivity in adipose tissue (Balogh et al. 2008). The concentration of antilipolytic insulin is lower during early lactation, relative to late gestation, which is accompanied by
increased FFA mobilization. Block and coworkers (2003) determined that leptin concentrations
are low during the transition from gestation to lactation, a change that may be mediated in part by
insulin and may regulate feed intake, and energy expenditure (Yamada et al., 2003). Epinephrine
is another critical hormone that stimulates FFA mobilization and gluconeogenesis at parturition
(Sacca et al., 1983). Collectively, the endocrine status of the peripartal cow changes dramatically
during the peripartum to provide energy for fetal growth, the gravid uterus, and the neonate.

Carbohydrate Metabolism
The carbohydrate glucose is a major source of energy for all mammals to maintain their
normal physiological status (Aschenbach et al., 2010). The dairy cow uses glucose for maintenance
of basal tissue functions, support fetal growth, and for the mammary synthesis of milk lactose. Of
4

highest demand, the mammary gland can account for 50 to 85% of whole-body glucose uptake
(De Koster and Opsomer, 2013). In contrast to monogastrics, the dairy cow’s dependence on
glucose absorption from the small intestine is limited due to extensive carbohydrate fermentation
by the rumen microbiome (Mills et al., 1999; Aschenbach et al., 2010). To meet glucose demand,
the cow relies on hepatic gluconeogenesis utilizing rumen-derived propionate as the major
precursor for hepatic glucose synthesis. The quantitative contribution of propionate during the
transition period is 60 to 70%, followed by lactate, glucogenic amino acids (AA), and glycerol (De
Koster and Opsomer, 2013). The relative contribution of glucogenic substrates can be modified by
feed composition, intake, stage of lactation, and energy balance. For instance, feeding a high
concentrate diet to peripartal dairy cows can shift the rumen microbiome toward amylolytic
bacteria as a means to increase lactate and propionate production (De Koster and Opsomer, 2013).
With certainty, propionate and lactate play a pivotal role as glucogenic substrate during late
gestation and early lactation (Drackley et al., 2001; Reynolds et al., 2003). Glucogenic AA (e.g.,
alanine and glutamine derived from the catabolic breakdown of skeletal muscle) contribute to
gluconeogenesis during the transition period, more so than other stages of lactation (Drackley et
al., 2001). Specifically, alanine accounts for 24% of nitrogen-derived AA in portal circulation and
is considered the predominant glucogenic AA precursor in dairy cattle (Reynolds et al., 1991).
Additionally, lipolysis-derived glycerol is converted to dihydroxyacetone phosphate and
glyceraldyde 3-phosphate to support glucose synthesis during negative energy balance (NEB), the
predominant physiological state of early lactation. However, glycerol is a minor contributor to
hepatic glucose synthesis, relative to the other precursors described.
The key regulatory enzymes of gluconeogenesis include phosphoenolpyruvate
carboxykinase and pyruvate carboxylase. During the transition from gestation to lactation, mRNA
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abundance of phosphoenolpyruvate carboxykinase and pyruvate carboxylase are responsive to the
onset of calving (Greenfield et al., 2000). Specifically, hepatic phophoenolpyruvate carboxykinase
mRNA is elevated by d 28 postpartum, relative to prepartum levels, and hepatic mRNA expression
of pyruvate carboxylase increases postpartum (Greenfield et al., 2000; Hartwell et al., 2001). These
changes in hepatic gene transcription support the maintenance of glucose homeostasis during the
peripartum.
Glucose disappearance from circulation involves two distinct processes: facilitated
diffusion and cotransport. The majority of glucose uptake occurs by facilitated diffusion via
glucose transporters (GLUT; Zhao and Keating, 2007). GLUT1 has ubiquitous distribution in all
tissues and is mainly responsible for basal glucose uptake. GLUT4 is the only insulin-regulated
transporter which is responsible for glucose uptake in skeletal and cardiac muscle as well as
adipose tissue, a transporter that translocates to the plasma membrane in response to insulin
receptor binding (Watson et al., 2004; Watson and Pessin, 2006). During late gestation and early
lactation, skeletal muscle and adipose tissue GLUT4 translocation to the plasma membrane
decreases due to reduced insulin action; however, GLUT1 mRNA expression increases to enhance
insulin-independent glucose uptake by the gravid uterus, fetus, and mammary gland (Zhao and
Keating, 2007).
Glycogen serves as the storage form of glucose in liver and skeletal muscle tissues. Only
the liver can provide glucose to blood circulation due to the conversion of glucose-6-phosphate
into glucose via the actions of glucose-6-phosphatase (De Koster and Opsomer, 2013). Because
liver glycogen pools are limited, the contribution of glycogenolysis to blood glucose levels is
minor during the peripartal period (Veenhuizen et al., 1991; Karcagi et al., 2008). Reduced insulin
levels during the peripartum are associated with reduced hepatic glycogenesis (Brockman and
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Laarveld, 1986). In a reciprocal fashion, circulating glucagon concentrations increase during early
lactation as a means to enhance gluconeogenesis and glycogen breakdown (de Boer et al., 1985).
Overall, the simultaneous rise in circulating glucagon levels coupled with the fall in circulating
insulin concentrations during early lactation modifies hepatic glucose metabolism to maintain
blood glucose supply (Rooyackers and Nair, 1997; Aschenbach et al., 2010).

Lipid Metabolism
During the transition period, adipose tissue metabolism shifts from lipogenesis to lipolysis
to meet the energy requirements of the cow experiencing NEB (McNamara, 199; Patterson et al.,
1994). The state of energy deficit is characterized by increased adipose tissue FFA mobilization
from TAG deposits due to decreased plasma insulin concentrations, a progressive increased
refractoriness of adipose tissue to insulin action (Bell and Bauman, 1997), increased activity of
adipose tissue lipases such as hormone sensitive lipase and TAG lipase (Langin et al., 2005), and
increased circulating levels of catecholamines, growth hormone and glucocorticoids (Contreras
and Sordillo, 2011). In turn, circulating FFA are primarily used for oxidative phosphorylation by
peripheral tissues, re-esterification of milk fat TAG in mammary tissue, formation of hepatic
ketone bodies (i.e., BHBA), and/or re-esterification to form neutral lipids such as TAG in liver.
Although adipose tissue lipolysis can provide glycerol for hepatic gluconeogenesis, an increased
concentration of FFA in circulation is associated with increased hepatic TAG accumulation. If
TAG accumulation is severe in liver, then fatty liver disease can develop in dairy cows
(Rukkwamsuk, 1998; Drackley, 1999). Unfortunately, hepatic gluconeogenesis and glycogen
storage are suppressed in cows experiencing fatty liver (Overton and Waldron, 2004).
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Changes in hepatic TAG accumulation may be due in part to compromised mitochondrial
fatty acid oxidation. First, hepatic oxidation of long-chain fatty acids (LCFA) involves increased
activity of multiple key enzymes including acyl-coA synthetase to activate LCFA for oxidation
and carnitine palmitoytransferase Ι to import LCFA into mitochondria (Drackley et al., 2001;
Louet et al., 2001). In the liver, the capacity of FFA oxidation can be influenced by the rate of FFA
uptake. Unfortunately, the dairy cow’s ability to completely oxidize palmitate to CO2 does not
increase during the peripartum (Litherland et al., 2011). Meantime, incomplete oxidation and reesterification is increased during the transition from gestation to lactation. Interestingly, the
transcription factors sterol regulatory element binding protein-1 (SREBP-1) and peroxisome
proliferator activated receptor-α (PPARα) may mediate oxidative metabolism during the
peripartum (Li et al., 2014; Shahzad et al., 2014). Although the hepatic expression of anabolic
SREBP1 is lowest during early lactation (Loor et al., 2005), PPARα activation is also reduced
(Shahzad et al., 2014). Inactivation of PPARα may represent the cause of impaired fatty acid
oxidation which likely supports the partitioning of fatty acids to alternative metabolic fates
including TAG (i.e. fatty liver), phospholipids, or sphingolipids.

Protein Metabolism
At the onset of lactation, the dairy cow in energy deficit experiences protein breakdown.
This catabolic change is mediated in part by insulin. Insulin can stimulate protein synthesis and
suppress protein degradation (Brockman and Laarveld, 1986); therefore, reduced circulating
insulin concentrations with concomitant increases in catecholamine levels and GH concentrations
can increase the flux of AA to the liver for hepatic gluconeogenesis and mammary gland for milk
protein synthesis (Kuhla et al., 2011). Of importance, GH serves as a promoter of AA uptake and
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incorporation into protein, particularly in skeletal muscle and mammary tissue (Machlin, 1976).
Obviously, this response is in contrast with the catabolism of protein reserve in the peripartal dairy
cow. It has been hypothesized that the capacity for the anabolic effects of GH in skeletal muscle
is small to favor the partitioning of nutrients toward the mammary gland (Bell, 1995).
Unfortunately, conventional mixed rations fed to dairy cows are inadequate in methionine (Met)
and lysine (Lys), the two essential rate-limiting AA for milk protein synthesis (NCR, 2001).
Supplementation of early lactation diets with rumen protected Met and Lys can improve milk yield
and protein synthesis (Lara, 2006; Socha, 2008).

Metabolic Disease and the Role of Insulin Resistance
It is well recognized that many of the metabolic diseases that develop during the transition
period are in association with insufficient energy intake and increased energy requirements for
lactation (Curtis et al., 1985). First, the dairy cow has an inherently low capacity to export TAG
within very low density lipoproteins (VLDL) to blood (Kleppe et al., 1988; Pullen et al., 1990),
and excessive hepatic FFA infiltration can lead to TAG accumulation and the progression of fatty
liver (Bobe et al., 2004). Furthermore, excessive FFA uptake can increase ketone synthesis (e.g.,
BHBA) leading to subclinical or clinical ketosis and other associated metabolic disorders, such as
mastitis, metritis, milk fever, and displaced abomasum (Herdt, 2000; Bobe et al., 2004). Second,
the elevation in circulating FFA during NEB is associated with a dysfunctional immune system
(Sordillo et al., 2009; Sordillo and Raphael, 2013). For instance, the pro-inflammatory cytokine
tumor necrosis factor alpha (TNFα) promotes lipolysis and TAG accumulation, and decreases
gluconeogenesis in the liver (Kettelhut et al., 1987; Kushibiki et al., 2001; García-Ruiz et al.,
2006). Third, increased FFA influx in the liver is associated with elevated reactive oxygen species
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(ROS), which form lipid peroxides (Bernabucci et al., 2005). Lipid peroxides can reduce the ability
of immune cells to respond to infection (Pessayre et al., 2004; Spears and Weiss, 2008). As a
consequence, the combination of excessive FFA mobilization, hepatic TAG accumulation,
inflammation, and oxidative stress can compromise cow milk production, milk quality, and
longevity.

Insulin Signaling and Mechanisms of Insulin Resistance
Insulin is an anabolic peptide hormone produced by beta cells of the pancreatic islets of
Langerhans. Insulin is released into circulation, and signals through receptor tyrosine kinases
(Lemmon and Schlessinger, 2010). First, insulin binds to the α-subunit of the insulin receptor, and
activates the β-subunit through auto-phosphorylation of tyrosine residues (Ward and Lawrence,
2009). The activated receptor recruits and activates insulin receptor substrates (IRS; Sun et al.,
1993). In turn, phosphatidylinositol 3-kinase is activated, followed by the phosphorylation of
phosphatidylinositol 4,5-bisphosphate. This cascade of events results in the activation of protein
kinase B (Akt) which facilitates the translocation of GLUT to the plasma membrane.
When sensitive to insulin action, insulin stimulates glycogenesis, lipogenesis, glycolysis,
and protein synthesis (Brockman and Laarveld, 1986; Edgerton et al., 2006; Hayirli, 2006; Sjaastad
et al., 2010; Dimitriadis et al., 2011). In addition, insulin reduces lipolysis, protein degradation,
and glycogenolysis. During early lactation, dairy cows develop insulin resistance as a homeorhetic
adaptation to partition nutrients to the mammary gland for milk synthesis; however, accelerated
insulin resistance can promote excessive lipolysis and increase disease risk. Specifically, insulin
resistance can be defined as a state where normal concentrations of insulin elicit a reduced
biological response (Kahn, 1978). It can be characterized into 2 distinct entities (insulin sensitivity
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and insulin responsiveness). Insulin sensitivity is defined as the insulin concentrations needed to
induce a half-maximal response; whereas, insulin responsiveness is determined as the maximal
effect of insulin. It is well documented that insulin sensitivity and responsiveness decreases during
late gestation and early lactation in ruminants (De Koster and Opsomer, 2013). It is important to
mention that the development of insulin resistance can be specific to a certain metabolic process
within a given tissue (De Koster and Opsomer, 2013). For instance, reduced insulin response in
skeletal muscle can dampen the anabolic process of protein synthesis as well as glucose uptake.
Additionally, research has observed localized adipose tissue, but not hepatic, insulin resistance
during early lactation, as a result of reduced tyrosine phosphorylation of IRS-1 (Saltiel and Kahn,
2001; Zachut et al., 2013).
In monogastrics insulin resistance is correlated with elevated adiposity (Ross et al., 2001;
Hayashi et al., 2008). Dephosphorylated Akt, down-regulates downstream proteins such as
glycogen synthase kinase-3 and SREBP1, therefore reduces glycogen synthesis and lipogenesis,
respectively. Simultaneously, hormone-sensitive lipase is activated, resulting in increased
circulating FFA. In dairy cows that experience excessive body fat loss, adipose tissue insulin
resistance is associated with enhanced lipolysis (Zachut et al., 2013), thus, overweight cows that
mobilize more FFA may be more prone to insulin resistance, relative to their lean counterparts. De
Koster and coworkers (2015) evaluated the effect of adiposity on insulin resistance at the end of
the dry period. The results demonstrated a negative correlation between steady-state glucose
infusion rate and adiposity. Effects on insulin sensitivity may depend on dietary energy intake,
rather than adiposity. For instance, glucose tolerance was evaluated in peripartal dairy cows
offered three planes of nutrition during the dry period (controlled, intermediate, and high energy
diet). Plane of nutrition did not modified glucose tolerance parameters (Mann et al., 2016). The
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uncertainty between overnutrition and systemic insulin action represents a gap of knowledge that
should be explored.

Measurement of Systemic Insulin Sensitivity in Dairy Cows
Because of the importance of insulin resistance to lactation and metabolic health, it is
critical to identify accurate and efficient approaches for measuring insulin sensitivity and
responsiveness in dairy cows. It is also important to recognize that the majority of glucose uptake
takes place independent of insulin action during established lactation. Therefore, one should be
cautious when assessing direct measures of systemic insulin sensitivity during active milk
synthesis.

Direct Measurements, Hyperinsulinemic-Euglycemic Clamp
The hyperinsulinemic-euglycemic clamp (HEC) procedure is considered as the gold
standard to measure insulin sensitivity in humans and animals (Defronzo et al., 1979). First,
exogenous insulin is administered as a priming dose followed by constant infusion of insulin (0.1,
0.5, 2 and 5 mIU/kg/min; De Koster et al., 2016) to raise blood insulin levels to a steady-state
level. This is referred to as the hyperinsulinemic plateau. Simultaneously, blood samples are
collected at regular intervals (~5 to 20 minutes) to measure blood glucose concentrations. To
achieve euglycemia (i.e., maintain normal fasting blood glucose levels), the dose of glucose
infused is calibrated based on repeated measurements of blood glucose concentrations. The steadystate of glucose can be explained as no change in glucose infusion required to maintain glucose
concentrations at the fasting or basal value (Ferrannini and Mari, 1998; De Koster and Opsomer,
2013). The assessment of insulin sensitivity is characterized by the steady-state insulin
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concentration (SSIC) and the steady-state glucose infusion rate (SSGIR). A higher SSGIR is
indicative of high insulin-stimulated glucose uptake by peripheral tissues (De Koster and Opsomer,
2013). Additionally, the insulin sensitivity index can be calculated as either SSGIR/SSIC
(Mitrakou et al., 1992) or as SIclamp. SIclamp is defined as M/(G × ΔΙ), where M is glucose disposal
rate, G is steady-state blood glucose concentrations, and ΔΙ is the difference between fasting and
steady-state blood insulin concentrations (Muniyappa et al., 2008). The greater SIclamp, the higher
is systemic insulin sensitivity. Although the HEC is the most accurate method to evaluate insulin
sensitivity in dairy cows, the technique has major disadvantages such as being laborious,
expensive, time consuming, and requires some degree of experience (De Koster and Opsomer,
2013; De Koster et al., 2016). Therefore, other direct and indirect methods have been employed to
evaluate insulin sensitivity in dairy cows.

Direct Measurements, Glucose Tolerance Testing
The glucose tolerance test (GTT) is a more applied method to estimate systemic insulin
sensitivity in dairy cows (De Koster and Opsomer, 2013). In detail, cows are intravenously infused
with a supraphysiological dose of glucose (150 to 500 mg/kg; Holtenius et al., 2003; Pires et al.,
2007; Kerestes et al., 2009). Blood samples are taken at a regular interval of 10 to 20 minutes to
determine insulin, FFA, and glucose concentrations in response to the challenge. Glucose
concentrations measured during the GTT reflect a combination of excretion and absorption from
different tissues (e.g., liver, mammary gland, intestine, gravid uterus, and skeletal muscle). The
concentration of insulin reflects secretion from the pancreas and uptake of insulin by the liver.
Clearance rate, area under the curve (AUC), time to reach basal and half of maximal concentrations
of glucose and insulin can be calculated (Pires et al., 2007). A low rate of glucose clearance, high
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AUC for glucose, and increased time to reach basal glucose concentrations can be considered as a
state of insulin resistance in dairy cows (De Koster and Opsomer, 2013).

Direct Measurements, Insulin Tolerance Testing
An insulin tolerance test (ITT) involves the administration of insulin (i.v. 0.02 to 0.1 U/kg;
McCann and Reimers, 1985; Oikawa and Oetzel, 2006; Pires et al., 2007). Comparable to a GTT,
blood samples are collected at regular intervals following the challenge. Circulating insulin and
glucose can be measured. Glucose clearance rate, blood glucose reduction (% from basal glucose),
and AUC for glucose after insulin administration can be calculated. Insulin resistance is defined
as a low insulin-stimulated reduction of blood glucose levels from measurements made in the basal
state, low glucose clearance, and elevated glucose AUC (De Koster and Opsomer, 2013). Previous
work has demonstrated that insulin tolerance decreases in Holstein cows infused with a tallow
emulsion (Pires et al., 2007). The main disadvantage of the ITT is elicited hypoglycemia and the
potential neurologic danger of the test (Ferrannini et al., 1998).
Overall, multiple physiological factors for selecting a direct method to measure insulin
sensitivity in dairy cows should be considered. Additionally, cost and applicability of the direct
method should be considered. Because of these considerations, the dairy science research field is
exploring the use of more affordable and less intensive indirect measures for insulin sensitivity
(Koster and Opsomer, 2013)

Indirect Measurements, Insulin Sensitivity Indices
Indirect methods of estimating systemic insulin sensitivity have been developed in human
medicine and have been utilized in dairy research due to their simplicity of use and potential
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effectiveness (Table 2-1: De Koster and Opsomer, 2013); however, these efforts have been
contested (Mann et al., 2016). The indirect methods predict insulin sensitivity based on blood
samples collected following an overnight fasting (Muniyappa et al., 2008). First, the homeostasis
model assessment of insulin resistance (HOMA-IR) is developed (Matthews et al., 1985) to predict
insulin resistance and β-cell function based on a fasting steady-state glucose and insulin values.
Second, the quantitative insulin sensitivity check index (QUICKI) is a mathematical model based
on the reciprocal log transformation of basal glucose and insulin concentrations (Muniyappa et al.,
2008). The higher the HOMA-IR, the greater the insulin resistance of an individual. Whereas, a
higher QUICKI value can be interpreted as lower insulin resistance. First developed for
biomedicine (Perseghin et al., 2001; Rabasa-Lhoret et al., 2003), the revised quantitative check
index (RQUICKI) has been shown to improve QUICKI correlation with the clamp-based index of
insulin sensitivity (Perseghin at el., 2001). The RQUICKI was first modified to become
RQUICKIBHBA by adding basal plasma concentrations of BHBA (Balogh et al., 2008).
Interestingly, the RQUICKIBHBA has never been tested in human medicine.
Table 2-1: Common surrogate indices for insulin sensitivity.
Surrogate Indices

Equation

Reference

HOMA-IR

[glucose (mmol/L) × insulin (µU/mL)/22.5]

Muniyappa et al., 2008

QUICKI

1/[log insulin (µU/mL) + log glucose (mg/dL)]

Katz et al., 2000

RQUICKI

1/[log glucose (mg/dL) + log insulin (µU/mL) + log FFA (mmol/L)]

Perseghin et al., 2001

RQUICKIBHBA

1/[log glucose (mg/dL) + log insulin (µU/mL) + log FFA (mmol/L) + log BHBA (mmol/L)]

Balogh et al., 2008

These indirect models have been used in veterinary medicine; however, limited dairy
science research has evaluated their efficacy relative to direct measurements (De Koster and
Opsomer, 2013). Because direct methods to measure insulin sensitivity in dairy cows are laborious
and expensive; the application of an indirect method to estimate insulin sensitivity was first
adopted by Holtenius and Holtenius (2007). They estimated insulin sensitivity in the first 15 weeks
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of lactation, and reported that RQUICKI may be used to determine insulin resistance in dairy cows.
The RQUICKI value was not significantly changed over time. Additionally, results demonstrated
a negative relationship between RQUICKI value and subcutaneous adiposity. Interestingly,
indirectly they found positive relationship between RQUICKI and GTT values. The RQUICKI
approach is the most commonly used index in dairy science (Holtenius and Holtenius, 2007;
Balogh et al., 2008; Kerestres et al., 2009; Mann et al., 2016). However, a concern is whether these
indices are comparable to direct measures. Few studies have been evaluated the association
between insulin resistance indices with direct methods in periparturient dairy cows. De Koster et
al (2016) validated different measures of insulin sensitivity of glucose metabolism in dairy cows
during the dry period. Results indicated no association between an HEC test and RQUICKI values.
Furthermore, Mann et al (2016) investigated the relationship between a GTT and surrogate indices
in dry period of dairy cows offered three plane of nutrition. Correlation between indirect methods
and GTT parameters were generally poor. The lack of correlation between direct and indirect
methods likely reflect changes in FFA, glucose, and insulin over time; particularly in early
lactation period. Moreover, the influence of the mammary gland, which uptakes glucose
independent of insulin, is of concern. Additionally, these tests are often performed in the fed state
(i.e. ruminants do not fast because of rumen feed retention). These uncertainties raise questions
related to the usefulness of surrogate indices in dairy cows since glucose and insulin kinetics differ
from human.

Biomarkers for Metabolic Disease
The prevalence of metabolic disease is high during the transition from gestation to
lactation, affecting on average 40% of the dairy cow population (LeBlanc, 2010). As previously
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stated, a postpartum disease can compromise milk production, fertility, and increase treatment
costs and culling rates (Grӧhn et al., 1998; Grӧhn et al., 1999; Duffield et al., 2009). Thus, early
detection of post metabolic disease has the potential to prevent a disease from developing and thus
improve milk production, fertility, and profitability (Saleem et al., 2012; Hailemariam et al., 2014;
Kenéz et al., 2016). Currently, circulating FFA and BHBA are industry standard biomarkers for
metabolic disease. Laboratory and cow-side tests have been developed to monitor FFA and BHBA
levels, respectively. The alarm threshold levels for poor reproductive performance and milk
production for prepartum FFA and BHBA are 0.27 mEq/L and 10 mg/dL, respectively; and
postpartum FFA of 0.60 mEq/L (Ospina et al., 2010). The limitations for testing for FFA and
BHBA include (A) these metabolite thresholds represent the disease state (rather than pre-onset
disease which would be preferred), (B) they ignore the interactions between other causative
metabolites of metabolic disease, (C) laboratory testing is expensive, and (D) individual cow blood
sampling is impractical. Therefore, alternative biomarkers for postpartum metabolic disease are
needed.
Metabolomics and lipidomics are systems biology approaches that have emerged in the
field of life sciences (Fischer, 2008; Nam et al., 2015). These omics approaches rely on mass
spectrometry to profile the metabolome (i.e., the comprehensive set of metabolites in a biological
matrix). Lipidomics and metabolomics produce large-scale data sets that when analyzed with
appropriate bioinformatic tools, can expand our understanding of energy metabolism. These omics
approaches have been routinely utilized to identify predictive biomarkers for insulin resistance and
non-alcoholic fatty liver disease in humans (Haus et al., 2009). For instance, lipidomics approach
identified lysophosphatidylcholine (LPC), particularly LPC 16:0, as the key metabolite in fatty
liver-induced

insulin

resistance

in

humans

(Lehmann
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et

al.,

2013).

Additionally,

phosphatidylcholine (PC) 32:3 is positively associated with nonalcoholic fatty liver insulin
resistant humans (Lehmann et al., 2013). A targeted metabolomic approach has been used to
identify serum PC 32:1, 36:1, 38:3, and 40:5 as biomarkers for type 2 diabetes (Floegel et al.,
2013). The routine prevalence of PC as a biomarker for metabolic disease is likely due to the
importance of PC for hepatic VLDL assembly and secretion (Cole et al., 2012). Because VLDL
secretion is suppressed in dairy cows with fatty liver disease, and dietary choline intake is limited
during the peripartum, research should evaluate whether circulating PC is representative of hepatic
steatosis in dairy cattle as well.
Metabolomics and lipidomics have been limitedly employed to identify biomarkers of
insulin resistance, hepatic lipidosis, mastitis, metritis and clinical and subclinical ketosis in dairy
cows (Hailemariam et al., 2014; Imhasly et al., 2014; Sun et al., 2014; Imhasly et al., 2015; Rico
et al., 2015). For instance, Hailemariam et al. (2014) conducted a longitudinal and cross-sectional
metabolomic study to characterize the patterns and changes of plasma metabolites before and after
the onset of metabolic disorders in dairy cows. They reported 3 metabolites (carnitine, propionyl
carnitine, and lysophosphatidylcholine) that can predict multiple postpartum diseases including
metritis, mastitis, laminitis, and retained placenta 4 weeks before initiation; moreover, 2 PC
species (PC 42:2 and 42:6) reported to possibly predict disease a week before its appearance.
Moreover, carnitine and LPC C16:0 have emerged as biomarkers of immune activation (Sampey
et al., 2012; Kabarowski et al., 2002; Drobnik et al., 2003). Furthermore, a dairy metabolomics
study was conducted to identify serum biomarkers as an alternative diagnostic approach for hepatic
lipidosis (Imhasly et al., 2014). They identified 29 metabolites particularly several PC and
sphingomyelins. The major metabolites to distinguish between control and diseased dairy cows
were PC 30:2, 32:2, 36:2, 36:3, 36:4, 38:3, 38:4, 38:6, 40:2, 40:3, 40:4, and 42:2. In addition, the
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usefulness of metabolomics approach has been evaluated in dairy cows to identify healthy cows
from cows affected by ketosis (Zhang et al., 2013; Sun et al., 2014). Their results demonstrated
2,3,4-trihydroxybutyric acid, α-aminobutyric acid, methylmalonic acid, sitosterol ,and αtocopherol as potential biomarkers for ketosis. Further, lipidomics results from our lab, established
sphingolipid ceramide as a predictive biomarker of insulin resistance in peripartal dairy cows (Rico
et al., 2015, Rico et al., 2016). Although omics data has emerged, data investigating the link
between biomarkers and the mechanisms that mediate metabolic disease are non-existent and the
inclusion of hypothesis-driven research that applies omics should be a requirement.
Biomarker discovery should focus on hepatic lipid export, considering that fatty liver
disease can promote ketosis. Specifically the dairy cow’s limited capacity to remove TAG from
the liver is important contributor to postpartum fatty liver disease (Pullen et al., 1990). Therefore,
identifying markers for VLDL assembly represents an approach to improve hepatic health. What
represents a challenge is that impaired VLDL export might involve multiple factors. First, the
hepatic mRNA expression and circulation of Apo B100 decreases as parturition approaches
(Bernabucci et al., 2004). Second, FFA can reduce VLDL export by decreasing the abundance of
microsomal transfer protein in the FFA-treated hepatocytes (Lei et al., 2014). Third, possibly the
most important reason for impaired VLDL export is due to limited hepatic phospholipid sources
(Van den Top et al., 1996; Kessler et al., 2014). Phosphatidylcholine is the major form of choline
phospholipids and is the main component of VLDL (Zeisel, 1992). Reduced hepatic PC levels
impair liver VLDL export (Verkade et al., 1993; Fast and Vance, 1995). Noticeably, reduced PC
synthesis impair VLDL export in animals fed choline-deficient diets (Li and Vance, 2008).
Further, phophatidylethanolamine is required for nascent VLDL assembly (Hamilton and Felding,
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1989). Thus, to facilitate lipoprotein export, PC and PE likely play a vital role and deserve further
attention as potential markers for metabolic disease.
Collectively, lipidomics and metabolomics provide a global assessment of metabolite
changes; however, we must carefully ensure that newly discovered biomarkers are tested for their
efficacy. Once identified and tested, novel diet formulations can be created to target these newly
discovered biomarkers, and new affordable prognostic and diagnostic testing procedures can be
implemented to improve dairy cow health and performance.
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CHAPTER 3
COMPARATIVE EFFECTS OF ADIPOSITY ON DIRECT AND INDIRECT
MEASUREMENTS OF INSULIN SENSITIVITY IN PERIPARTURIENT DAIRY
COWS.

ABSTRACT
Insulin resistance in periparturient dairy cows develops as a means to support lactation;
however, the excessive mobilization of free fatty acids (FA) from adipose tissue can increase
metabolic disease risk. Moreover, prepartum adiposity is a risk factor for the lipolytic release of
FA and hepatic lipid deposition. Our primary objective was to investigate the effect of prepartum
adiposity on systemic glucose and insulin tolerance in lean and overweight periparturient dairy
cows fed common diets. Our secondary objective was the comparative evaluation of direct and
indirect measurements of insulin sensitivity in peripartal dairy cows. Twenty-one multiparous
Holstein cows were allocated into 2 groups according to their adiposity at d -28 prepartum: lean
(body condition score (BCS) ≤ 3.0) or overweight (BCS ≥ 4.0). All cows were ad libitum fed diets
formulated to meet or exceed nutrient requirements. Blood and milk samples were collected
routinely. Prior to morning feeding, liver biopsies were collected on d -27, -14, and 4, relative to
expected calving. An intravenous insulin (0.1 IU/kg of body weight; ITT) or glucose (300 mg/kg
of body weight; GTT) challenge was performed following each liver biopsy. Plasma FA, insulin,
glucose, and β-hydroxybutyrate (BHBA) concentrations were measured. Surrogate indices of
insulin sensitivity were calculated. Data were analyzed as repeated measures using a mixed model
with fixed effects of adiposity and time. Overweight cows had lower dry matter intake and lost
more adiposity during the peripartum, relative to lean cows. Overweight cows had increased
plasma FA and BHBA concentrations, and elevated liver lipid content. In support of impaired
insulin sensitivity, GTT glucose clearance rate (30 min post-glucose infusion) was lower for all
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cows postpartum. Prepartum adiposity had minimal effects on multiple ITT and GTT glucosedependent parameters; however, the ability of the cow to restore blood glucose levels following
an insulin challenge was suppressed by increased adiposity. Additionally, overweight cows
experienced lower glucose-stimulated reductions in FA following a glucose challenge.
Collectively, glucose-dependent parameters of insulin and glucose tolerance were not correlated
with surrogate indices of insulin sensitivity. We conclude that prepartum adiposity had no effect
on systemic insulin sensitivity following parturition. Observed inconsistencies between surrogate
indices for insulin sensitivity and direct measurements of insulin and glucose tolerance raises
concerns regarding whether their application to estimate systemic insulin action in periparturient
cows is suitable.
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INTRODUCTION
Dairy cattle transitioning from gestation to lactation will partition glucose away from
adipose and skeletal muscle tissues, and toward the mammary gland as a means to support lactose
synthesis (Bell, 1995). The adaptive change in peripheral glucose utilization during the
periparturient period is caused in part by decreased insulin sensitivity (Bell and Bauman, 1997).
Reduced insulin signaling in adipose tissue occurs in parallel with enhanced lipolysis of
triacylglycerol during early lactation. The postpartum elevation in circulating fatty acids (FA) will
promote hepatic lipid deposition and ketogenesis in the early lactation cow, peripartal risk factors
for the development of fatty liver disease and ketosis.
An increase in prepartum adiposity can predispose dairy cows to a greater magnitude of
FA mobilization during early lactation (Holtenius et al., 2003; Holtenius, 2007). Others have
proposed that a greater extent of adipose tissue insulin resistance in overweight peripartal dairy
cows may contribute to excessive lipolysis thus greater metabolic disease risk (Bossaert et al.,
2008), a response that may be mediated by the sphingolipid ceramide (Rico et al., 2015). Certainly
enhanced body fat accumulation can develop in dairy cattle fed in excess of energy requirements
during gestation, albeit dependent upon the length of the overfeeding regimen (Marrow, 1976;
Roche et al., 2013). Effort has been focused on the effects of plane of nutrition during the dry
period on peripartal metabolic health and glucose disposal. For instance, feeding a high energy
diet to cows prepartum does not modify systemic glucose tolerance following a challenge
performed during late gestation or early lactation (Schoenberg and Overton, 2011; Schoenberg et
al., 2012; Mann et al., 2016). Moreover, the ability of prepartum nutrient excess to suppress FA
disappearance following a glucose challenge has been previously demonstrated during late
gestation (Schoenberg and Overton, 2011; Schoenberg et al., 2012); however, this finding is in
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contrast to recent observations made during the peripartal transition (Mann et al., 2016). It is
important to recognize that these studies utilized dairy cows with moderate adiposity at enrollment
(~3.0 body condition score; BCS), and prepartum elevated plane of nutrition resulted in minor
gains in adiposity during gestation (~0.25 BCS change).
Enhanced adiposity is associated with reduced systemic insulin sensitivity in fasted nonruminants (Ross et al., 2001; Hayashi et al., 2008); however, this view has been challenged by
others describing obese humans that are insulin-sensitive (Klӧting et al., 2010; Samocha-Bonet et
al., 2012). Suppressed insulin sensitivity may explain why overweight dairy cows during the
peripartal period exhibit greater FA mobilization postpartum. Pregnant cows with moderate body
condition that gain adiposity through wk 1 postpartum in response to high-energy feeding have
exhibited a decrease in glucose clearance rate postpartum (Holtenius et al., 2003a, b). In contrast,
glucose clearance rate was not related to BCS when recorded three weeks postpartum in dairy
cows with moderate FA mobilization (Jaakson et al., 2013). Recently, De Koster and coworkers
(2015) evaluated nine Holstein Friesian dairy cows during late gestation with variable BCS
(Wildman et al., 1982), and observed that maximal steady-state glucose infusion rate during a
hyperinsulinemic-euglycemic clamp was inversely related with BCS and basal circulating FA
concentrations. Undoubtedly differences in experimental designs, feeding regimens, magnitude of
adiposity, metabolic status, and method of insulin sensitivity assessment during the peripartum
confound our understanding of insulin action in peripartal dairy cows.
Several surrogate measures have been employed to evaluate insulin sensitivity in
monogastrics and ruminants. These insulin sensitivity indices rely on the measurement of
circulating FA, glucose, insulin, and β-hydroxybutyrate (BHBA) levels in the basal state (Kerestes
et al, 2009; Mann et al., 2016). Initially evaluated in dairy cows by Holtenius and Holtenius (2007),
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the Revised Quantitative Insulin Sensitivity Check Index (RQUICKI) has received considerable
attention (Schoenberg et al., 2011; Rico et al., 2015; Mann et al., 2016). However, Mann and
colleagues (2016) recently discovered that peripartal glucose tolerance in cows fed different planes
of nutrition prepartum did not correlate with multiple indices of insulin sensitivity including
RQUICKI, and stated that indice values should not be compared across stages of lactation.
Our primary objective was to examine the effect of adiposity on glucose disposal in
response to repeated intravenous glucose and insulin tolerance tests performed in lean and
overweight periparturient dairy cows ad libitum fed common diets. Considering the recent
uncertainty related to the application of surrogate indices of insulin sensitivity, our secondary
objective was the comparative evaluation of direct and indirect measurements of insulin sensitivity
in periparturient dairy cows with contrasting adiposity.

MATERIALS AND METHODS
Experimental Design
Experimental procedures were approved by the Institutional Animal Care and Use
Committee at West Virginia University (Morgantown). The experiment was completed at Dovan
Farms (700-cow Holstein dairy herd; Berlin, PA), a West Virginia University Agricultural
Research and Education Partner. Twenty-one multiparous Holstein cows (parity 2 to 4) were
enrolled 28 d before expected parturition, and immediately allocated to one of two groups
according to their adiposity, as either lean (BCS = 2.93 ± 0.16) or overweight (BCS = 4.01 ± 0.20).
Cows were housed on a straw bedded pack and trained to access feed from Calan gate feeders
(American Calan, Inc., Norwood, NH) from enrollment through 6 DIM. Because of farm
management constraints, cows were moved to adjacent free-stalls from 7 DIM through study
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completion. Diets provided ad libitum were composed of corn silage and grass haylage as the main
forage components, and were formulated to meet or exceed nutrient recommendations (Table 3-1;
NRC, 2001). Cows were fed once (0800 h) and twice (0800 and 1900 h) daily during pregnancy
and lactation, respectively, and free access to water was provided.

Sample Collection
Samples of TMR were collected weekly throughout the experiment. Blood collection (10
mL) by coccygeal venipuncture occurred prior to morning feeding on d -28, -21, -14, -7, and -5,
relative to expected calving, and d 0, 2, 4, 7, 14, and 21 postpartum. Blood was placed on ice for
30 min until centrifugation at 3,400 × g for 10 min. Following centrifugation, EDTA-preserved
plasma was removed and snap-frozen in liquid nitrogen, and then stored at -80 ºC until further
analysis. Cows were milked twice daily at 0800 and 1800 h. Milk yields were continually recorded
and milk samples were collected at each milking on d 2 , 3, 4, 5, 6, 7, 10, 14, and 21 postpartum.
A single milk aliquot was stored with bronopol at 4°C for component analysis. Body weights and
BCS were recorded weekly.
Liver tissue biopsies were performed prior to morning feeding on d -27 and -14, relative to
expected calving, and d 4 postpartum. Cows were anesthetized using xylazine (0.04 mL/kg of BW)
delivered via the coccygeal vein. After the hair was clipped, the biopsy site located within the 11th
intercostal space was scrubbed with iodine and anesthetized with 5 mL of 2% lidocaine HCl
(Vedco Inc., Saint Joseph, MO) delivered subcutaneously. A 0.5 cm incision was made through
the skin and a fabricated trocar (Hughes, 1962) was utilized to collect approximately 1 g of liver
tissue. Liver tissue was immediately snap-frozen in liquid nitrogen and stored at -80°C. Following
each tissue collection, the biopsy site was stapled and sprayed with antiseptic, and ceftiofur
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hydrochloride antibiotic was delivered once by intramuscular injection (0.68 mL/kg of BW;
Excenel RTU; Zoetis, Florham Park, NJ).

Glucose and Insulin Tolerance Testing
Immediately following each liver biopsy, jugular catheters were inserted and patency was
maintained by flushing with heparinized saline every 12 h for 2 d. Intravenous insulin and glucose
tolerance tests (ITT and GTT, respectively) were performed using previously described methods
(Pires et al., 2007). Briefly, feed was removed 2 h prior to tolerance testing. An intravenous ITT
(0.1 IU of insulin per kg BW; Humulin R; Eli Lilly and Co., Indianapolis, IN) was performed on
d -26 and -13 before expected calving, and on d 5 postpartum. An intravenous GTT was performed
on d -25 and -12, relative to expected calving, and d 6 postpartum. Cows were intravenously
infused with 300 mg of glucose (dextrose, 50% wt/vol) per kg of BW. Glucose infusion occurred
within 8 ± 2 min, and was followed by a 10-mL saline flush. For GTT and ITT, blood samples (10
mL) were collected at -10, 0, 10, 20, 30, 40, 60, 90, 120, 150, and 180 min relative to initiation of
challenge. Blood was processed as described above. Feed was provided immediately following the
completion of testing.

Sample Analyses
Weekly TMR samples were analyzed for DM content by drying at 60°C until a static weight
was observed. Nutrient composition of TMR was analyzed using near-infrared spectroscopy
(AOAC method 989.03) by Cumberland Valley Analytical Services Inc. (Cumberland, MD).
Plasma samples were analyzed in duplicate for nonesterified FA, insulin, glucose, and BHBA.
Plasma concentrations of FA, glucose, and BHBA were determined by enzymatic methods using
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commercial kits (HR series FA-HR (2), Autokit Glucose, and Autokit 3-HB, respectively; Wako
Chemicals USA Inc., Richmond, VA). Plasma insulin concentrations were determined by ELISA
(Mercodia Bovine Insulin ELISA; Mercodia AB, Uppsala, Sweden). Spectrophotometric
measurements were conducted using a SpectraMax Plus 384 Microplate Reader (Molecular
Devices, Sunnyvale, CA). Intra- and interassay coefficient of variations for all colorimetric assays
were <5 and <10%, respectively. Total liver lipid content was determined by extracting 100 mg of
liver tissue, as previously described (Hara and Radin, 1978; Piepenbrink and Overton, 2003).
Individual milk samples were analyzed for fat, true protein, and lactose concentrations (Dairy One,
Hagerstown, MD; AOAC, 1990; method 972.160).

Calculations and Statistical Analysis
The indices for insulin sensitivity quantitative insulin sensitivity check index (QUICKI;
Katz et al., 2000), RQUICKI (Perseghin et al., 2001), RQUICKI including BHBA (RQUICKIBHBA;
Balogh et al., 2008), and homeostasis model of insulin resistance (HOMA-IR; Muniyappa et al.,
2008) were calculated as follows: QUICKI = {1 / [log glucose (mg/dL) + log insulin (µU/mL)]},
RQUICKI = {1 / [log glucose (mg/dL) + log insulin (µU/mL) + log FA (mmol/L)]},
RQUICKIBHBA = {1 / [log glucose (mg/dL) + log insulin (µU/mL) + log FA (mmol/L) + log BHBA
(mmol/L)]}, and HOMA-IR = {[glucose (mmol/L) × insulin (µU/mL)] / 22.5}. Glucose clearance
rate (CR), time to reach half maximal concentration (T1/2), and time to reach basal concentration
(Tbasal) were calculated according to methods described by Pires et al. (2007): Glucose CR (%/min)
= [(ln glucose at 10 min – ln glucose at time point 60 min) / 60] × 100, T1/2 (min) = [(ln 2) / CR] ×
100, Tbasal (min) = [(ln glucose at 10 min – ln glucose at 60 min) / CR] × 100. The glucose area
under the curve (AUC) during a GTT was calculated using the trapezoidal method. Baseline
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glucose concentrations were calculated as the mean of measurements at -10 and 0 min, relative to
start of challenge. Changes in BCS and BW of lean and overweight cows were calculated as the
differences between values at d -21 prepartum and d 21 postpartum.
Changes in BCS and BW were analyzed under the GLM procedure of SAS (version 9.3;
SAS Institute Inc., Carry, NC). Plasma, liver, and milk variables were analyzed as repeated
measures over time relative to parturition under the MIXED procedure of SAS (SAS Institute Inc.).
The statistical model included the random effect of cow nested within BCS, and the fixed effects
of BCS, day relative to parturition, and their interaction. The most appropriate covariance structure
for the repeated measures analysis was selected for each variable after evaluating 3 different
covariance structures (variance components, first-order autoregressive, compound symmetry), and
the structure with the smallest Akaike’s information criterion coefficient was selected for analysis.
The method of Kenward-Rogers was used for calculation of denominator degrees of freedom.
When the BCS effect or BCS × day relative to parturition were significant, the SLICE option of
SAS was used to compare treatment differences at individual time points. Non-parametric
Spearman’s rank-order correlations were performed in order to determine associations between
surrogate indices of insulin sensitivity, direct measurements of insulin sensitivity, and plasma
metabolites. In order to reduce risk of type I error for repeated measures analysis, the significance
level was decreased to P ≤ 0.05, and trends toward significance were considered at 0.05 < P ≤
0.10. Studentized residual values >3.0 or <-3.0 were considered outliers and removed from the
analysis (typically 1 per response variable). All results are expressed as least squares means and
their standard errors, unless stated otherwise.
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RESULTS AND DISCUSSION
Although twenty-one prepartum cows were enrolled, 4 lean and 3 overweight cows were
not included within our analyses because they were diagnosed with a metabolic disease and
subsequently treated by the herd veterinarian; therefore, our data represents fourteen cows that
transitioned from gestation to lactation without clinical intervention. Overweight cows displayed
DMI suppression during the peripartum (Figure 3-1; P < 0.01), a response that may be regulated
in part by anorexigenic signals including circulating FA and BHBA (Laeger et al., 2012; Le Foll
and Levin, 2016). Certainly, reductions in DMI can exacerbate negative energy balance and
increase metabolic disease risk in cows with enhanced adiposity. As evidence, the transition from
gestation to lactation was accompanied by accelerated loss of BW (18 vs. 9%; P < 0.01) and BCS
(22 vs. 13%; P < 0.05) in overweight cows (Figure 3-1). Lactation performance was comparable
for lean and overweight cows; except, milk fat yield (P < 0.10) and content (P < 0.01) was greater
in cows with enhanced prepartum adiposity (Figure 3-2).
Basal measurement of systemic and hepatic health were performed to confirm that
prepartum adiposity is a risk factor for postpartum metabolic impairment (Figure 3-1). Plasma FA
concentrations were greater in overweight animals (P < 0.05), and maximum lipolysis was
observed at parturition with a 2.4-fold increase in circulating FA in overweight cows, relative to
lean cows (P < 0.001). Although the development of insulin resistance in overweight humans is
associated with elevated circulating FA, glucose, and insulin (Reaven et al., 1988; Thévenod,
2008), we recognize that the characteristic response to lactation and the progression of insulin
resistance in cows is a decrease in circulating insulin. Unlike our previous observations (Rico et
al., 2015), circulating insulin was numerically but not significantly higher in overweight cows
prepartum (P < 0.05); whereas, plasma insulin concentrations were similar for both adiposity
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groups during early lactation. The characteristic decline in circulating insulin observed for all cows
occurred in conjunction with reduced plasma glucose concentrations postpartum (P < 0.001),
although prepartum BCS did not influence systemic glucose supply. Due in part to increased
hepatic FA influx, liver lipid accumulation and plasma BHBA concentrations were elevated in
cows with enhanced gestational adiposity. The poor metabolic health observed in overweight cows
reinforces the importance of avoiding over-conditioning of cows during gestation.
Due to early parturition, the actual sampling day for each prepartum tolerance test was 20.5 ± 5.8 and -9.4 ± 3.5 for each ITT, and -21.3 ± 5.6 and -9.4 ± 3.5 for each GTT, whereas
postpartum ITT and GTT occurred as scheduled on d 5 and 6 postpartum, respectively. Several
methods have been utilized to evaluate insulin sensitivity. Insulin tolerance test was first developed
(Horgaard and Thayssen, 1929) to measure insulin sensitivity in vivo based on the clearance of
plasma glucose concentrations after injection of insulin bolus (0.1 U/kg BW). The main
disadvantage for any direct measurement of insulin sensitivity (especially during lactation) is that
glucose is primarily utilized by the mammary gland independent of insulin action (Bauman and
Currie, 1980; Pethick, 2005). Specifically, GLUT 1 and 3 in mammary gland are insulinindependent glucose transporters (Duehlmeier et al., 2005; Zhao et al., 2006) which makes
interpretation of results difficult. Although an insulin challenge lowered plasma glucose (P <
0.001), we did not observe an effect of adiposity pre and postpartum (Figure 3-3). However, we
did observe increased plasma glucose in lean cows 60 min post insulin challenge. Postpartum basal
glucose concentration was higher for lean cows during ITT (71.3 ± 6 vs. 65.1 ± 6 mg/dL, Table 32). The lowest concentration of glucose occurred 40 min after insulin challenge both pre- and
postpartum. The insulin dose administered in our research was similar to (Pires et al., 2007;
Kerestes et al., 2009), but lower than McCann and Reimers (1985), which is critical to consider
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when comparing results from different studies. We observed no differences between adiposity preand postpartum for reduction of glucose concentrations after insulin administration (Figure 3-3).
Following insulin-stimulated glucose disappearance, return to basal glucose in overweight cows
was delayed by 60 min (P < 0.05). Glucose utilization, hepatic glucose production, intestinal
glucose absorption and excretion of glucose by the kidney can determine the plasma glucose
concentrations (Pires et al., 2007) and glucose clearance during ITT can be interpreted as the
maximal glucose response to insulin challenge. In our study, adiposity did not impair glucose
clearance prepartum; however, overweight cows had delayed glucose return to their basal
concentrations, which indicates adiposity did not regulate systematic insulin resistance prepartum;
but probably reflects the postpartum insulin resistance induced by adiposity. The reason for
delayed glucose return to basal levels in overweight cows postpartum might be due to hepatic lipid
deposition blocking gluconeogenesis. The greater insulin-stimulated blood glucose reductions
after challenge indicates higher insulin sensitivity in peripheral tissues (De Koster and Opsomer,
2013), our findings indicate that glucose response to insulin was not impaired by adiposity that
were in contrast with Pires et al (2007) reports indicating impaired insulin responsiveness in
nonlactating, nongestating Holstein cows with hyperlipidemia. In addition, our findings were not
consistent with Kerestes et al (2009) where they observed higher glucose reduction after insulin
challenge in early lactation than prepartum, as well as an earlier return to basal glucose
concentrations (60 min) in obese after administering of high insulin dose (200 mU/kg). The
differences in findings can be explained by differences in experimental design, age of cows,
treatments, dose of insulin administered, and adiposity.
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Effect of adiposity on glucose response During GTT
We aimed to measure insulin sensitivity by evaluating glucose response during glucose
challenge. De Koster et al. (2016) validated different measures of insulin sensitivity during the dry
period. They reported a positive correlation between hyperinsulinemic euglycemic clamp (HEC)
and GTT parameters. The amount of glucose infused was greater than previous studies (Holtenius
et al., 2003; Pires et al., 2007; Mann et al., 2016) but lower than Kerestes et al. (2009). We did not
observe an effect of adiposity pre- and postpartum (Figure 3-4). Nevertheless, there were
significant interactions between adiposity and GTT, with overweight cows tended to have greater
glucose concentrations during the far-off at time point 40 min (P < 0.1) after glucose infusion. The
results indicate that adiposity does alter glucose metabolism during transition to lactation in dairy
cows. This is in agreement with studies investigating insulin sensitivity of Holstein cows varying
energy density during the dry period (Schoenberg et al., 2012; Mann et al., 2016). De Koster et al.
(2013) defined insulin resistance in dairy cows as a condition where glucose clearance is low, the
area under the curve for glucose is high, and time to reach basal glucose concentrations is high
during GTT. Post-glucose challenge of the glucose AUC for 60 min and CR of glucose for the first
30 min were lower (P < 0.05) and tended to be lower for AUC for 30 and 180 min for postpartum
cows, relative to prepartum cows (Table 3; P = 0.06). Our results are in contrast with Mann et al.,
(2016) which reported increased glucose clearance in postpartum cows. Although adiposity had
no effect on GTT; however, time to reach basal glucose concentrations was higher in overweight
cows postpartum (Table 3-3; P < 0.05). On the other hand, lower postpartum glucose CR in dairy
cows that are fed to gain body condition has been reported (Holtenius et al., 2003). Comparability
of GTT parameters of lactating cows with nonlactating, pregnant cows are intriguing; due to high
turnover of glucose in early lactation (De Koster and Opsomer, 2013) as it has been demonstrated
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by lower basal glucose concentrations postpartum (P < 0.01). Together, our findings suggest an
increased insulin resistance in early lactation regardless of adiposity.

Effect of Adiposity on FA Response During GTT
Plasma FA concentrations during GTT is depicted in Figure 3-5. Overweight cows had
greater FA concentrations in the far-off period at time point 120 min (P < 0.05) and tended to be
higher at time points 20, 30, 40 and 90 min (P < 0.1) relative to time after glucose infusion. We
observed higher FA concentrations in overweight cows during the entire close-up period and time
points 10 through 90 min postpartum (P < 0.05) with a tendency to be higher at time point 120
min postpartum (P < 0.1) after glucose challenge. Overweight cows experienced greater glucosestimulated FA reduction pre- and postpartum (Table 3-4; P < 0.05). These findings are in contrast
with results suggesting no effect of difference between plane of nutrition on FA metabolism preand postpartum (Mann et al., 2016). FA concentrations reached a nadir around time point 60 min
on close-up and postpartum after glucose challenge, which has delayed compare with previous
studies reported at 45 min (Zachut et al., 2013; Mann et al., 2016); that might be related to the dose
of glucose administered. This indicates the inhibition of lipolysis, after glucose infusion, in
response to insulin regardless of adiposity and physiological stage of a cow. Although we did not
observe an effect of adiposity on the percentage of FA reduction from baseline; however, we
observed increased post-glucose challenge of FA AUC for 60 through 180 min and reduced FA
CR for 60 through 180 min in postpartum, relative to prepartum (P < 0.01). The difference between
glucose and FA metabolism during peripartum was explained by De Koster et al. (2015) which
illustrated that lower insulin concentrations are needed to metabolize FA compare with its action
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on glucose metabolism. Together, our results reflect increased insulin resistance in early lactation
to partition nutrients to mammary gland as means to support milk synthesis.

Surrogate indices
We first evaluated the effect of adiposity on QUICKI, RQUICKI, RQUICKIBHBA, and
HOMA-IR values obtained during the peripartum (Figure 3-6). Surrogate indices have been
developed and validated, particularly QUICKI, in human medicine (Muniyappa et al., 2008).
Initially, RQUICKI has been utilized in dairy cows by Holtenius and Holtenius (2007) to evaluate
insulin sensitivity; with few other studies comparing HEC and GTT with insulin resistance indices.
Therefore, the lack of studies for evaluating surrogate indices in different adiposity during
peripatrum, necessitate the investigation in dairy cows. Comparable to previous findings
(Holtenius and Holtenius, 2007), enhanced adiposity was associated with a decrease in estimated
insulin sensitivity before and after parturition (P < 0.001), a response most pronounced for late
gestation (P < 0.05). In comparison to the effects of adiposity, changes in estimated insulin
sensitivity across time were inconsistent among surrogate markers. Whereas HOMA-IR decreased
and QUICKI increased with time (P < 0.01), reflecting an increase in estimated insulin sensitivity,
the transition from gestation to lactation was not accompanied by changes in RQUICKI or
RQUICKIBHBA. Considering that reduced insulin sensitivity is recognized as a homeorhetic
adaptation to lactation (De Koster and Opsomer, 2013), these discrepancies between indices are
concerning.
We next compared the index most often utilized in dairy science (Holtenius and Holtenius,
2007; Kerestes et al., 2009), RQUICKI with QUICKI, RQUICKIBHBA, and HOMA-IR; Table 35). We detected strong positive correlations between RQUICKI and QUICKI (ρ = 0.64; P ≤ 0.001),
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and RQUICKI and RQUICKIBHBA (ρ = 0.95; P ≤ 0.001). We also observed a strong inverse
relationship between RQUICKI and HOMA-IR (ρ = -0.63; P ≤ 0.001). These correlative
relationships were anticipated because higher QUICKI, RQUICKI, and RQUICKIBHBA, and lower
HOMA-IR values are indicative of reduced insulin action in monogastrics.
We further evaluated the correlation between surrogate indices and ITT, and GTT
parameters (Table 3-6). We hypothesized a strong association between IR indices and tolerance
tests during the peripartum. We observed positive correlation of glucose CR at time point 10 min
with RQUICKI (ρ = 0.38; P < 0.05), and RQUICKIBHBA (ρ = 0.32; P = 0.05). We observed no
other strong positive correlation between IR indices and tolerance tests. This is consistent with
previous studies (De Koster et al., 2016; Mann et al., 2016) which reported poor correlation or no
association between IR indices and direct measurement of insulin sensitivity. Insulin resistance in
dairy cows is very different than in humans due to the drastic physiological changes initiated in
the early lactation, especially for glucose, insulin, and FA metabolism. Consequently, usefulness
of surrogate indices in dairy cows can be questionable. It should be emphasized that comparing
results between different stages of lactation is not an accurate practice.

CONCLUSIONS
Although overweight dairy cows exhibit elevated prepartum insulin, postpartum FA, and
peripartal liver lipid deposition in parallel with a greater reduction in appetite, enhanced adiposity
during late gestation is not associated with modifications in glucose or insulin tolerance as assessed
by GTT or ITT. Furthermore, we agree with Mann and colleagues (2016) and reaffirm that the
usefulness of surrogate measures of systemic insulin sensitivity is indeed questionable, and that
investigators should refrain from comparing index values across the peripartal period.
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Figure 3-1. Metabolic health in lean and overweight dairy cows transitioning from gestation to
lactation. (A) Continuous DMI (kg/d). Plasma concentrations of (B) FA, (C) insulin, (D) regression
analysis of plasma insulin and BCS units, and (E) plasma concentrations of glucose. (F) Percent
liver lipid and (G) plasma concentrations of BHBA. Adiposity groups differed at each time point:
*, P < 0.05; †, P < 0.10. Data are represented as least squares means and their standard errors.
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Figure 3-2. Milk production data collected from postpartum lean and overweight dairy cows
transitioning from gestation to lactation. (A) The continuous evaluation of milk yield. Early
lactation yields (kg/d) of milk (B) fat, (C) protein, and (D) lactose in cows assigned as lean or
overweight -28 d prior to expected parturition. Differences in percent milk (E) fat, (F) protein, and
(G) lactose. Data are represented as least squares means and their standard errors.
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Figure 3-3. Plasma concentrations of glucose during an intravenous insulin tolerance test (ITT) performed
in lean or overweight peripartal cows. Insulin tolerance testing was completed at (A) 26 and (B) 13 d
prepartum, and (C) 5 d postpartum. Baseline measurements represent the average of samples
collected at -10 and 0 min relative to intravenous administration of 0.01 IU of insulin per kg of
BW. Fixed effects in model: BCS (not significant), Day < 0.001, and BCS × Day < 0.01. Adiposity
groups differed at each time point: *, P < 0.05; †, P < 0.10. Data are represented as least squares
means and their standard errors.
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Figure 3-4. Plasma concentrations of glucose during an intravenous glucose tolerance test (GTT)
performed in lean or overweight peripartal cows. Glucose tolerance testing was completed at (A)
25 and (B) 12 d prepartum, and (C) 6 d postpartum. Baseline measurements represent the average
of samples collected at -10 and 0 min relative to intravenous administration of 300 mg of dextrose
per kg of BW. Fixed effects in model: BCS (not significant), Day < 0.001, and BCS × Day < 0.05.
Adiposity groups differed at each time point: †, P < 0.10. Data are represented as least squares
means and their standard errors.
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Figure 3-5. Changes in plasma FA concentrations during an intravenous glucose tolerance test
(GTT) performed in lean and overweight peripartal cows. Plasma FA concentrations during GTT
completed on d (A) 25 and (B) 12 prepartum, and (C) d 6 postpartum. Baseline measurements
represent the average of samples collected at -10 and 0 min relative to intravenous administration
of 300 mg of dextrose per kg of BW. Fixed effects in model: BCS < 0.001, Day < 0.001, and BCS
× Day < 0.001. Adiposity groups differed at each time point: *, P < 0.05; †, P < 0.10. Data are
represented as least squares means and their standard errors.
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Figure 3-6. Surrogate indices of insulin sensitivity in lean and overweight periparturient dairy
cows. Estimated insulin sensitivity as measured by the (A) revised quantitative insulin sensitivity
check index (RQUICKI), (B) homeostasis model of insulin resistance (HOMA-IR), (C) QUICKI
and (D) RQUICKI including BHBA (RQUICKIBHBA). Description of abbreviations can be found
within Table 2. Data are represented as least squares means and their standard errors.
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Table 3-1. Ingredient and nutrient composition of diets.
Diets
Item
Gestation
Lactation
Ingredient (% DM)
Corn silage
30.7
42.4
Grass haylage
28.4
7.0
Grass hay
13.2
2.1
Dry ground corn
–
14.4
Prepartum mix1
13.9
–
2
Lactation mix A
–
14.0
Soybean meal
9.0
4.7
Cottonseed with lint
–
4.5
Sugar cane syrup
–
3.6
Lactation mix B3
–
4.5
4
Close-up supplement
4.8
2.7
Rumensin mix5
–
0.1
Nutrient composition
DM, %
55.5
51.6
NDF
48.3
37.6
Forage NDF
43.7
25.1
Forage NDF, % of NDF
90.5
66.7
ADF
32.0
25.2
CP
12.2
16.5
Starch
14.1
21.2
Crude fat
3.16
4.33
Ash
7.5
7.3
NEl, Mcal/kg DM
1.44
1.61
1

Mix contained 27% commercial dry cow mix with Animate (Phibro Animal Health Corp., Teaneck, NJ),
17.3% ground corn, 17.3% crimped oats, 13% corn distillers, 12.9% soybean meal, 4.3% calcium
carbonate, 4.3% calcium sulfate, 2.6% Omnigen AF (Phibro Animal Health Corp.), 1.1 Monocalcium
phosphate, and <1% of each of the following: Sel-plex 600 (Alltech Biotechnology, Nicholasville, KY)
and vitamin E.
2
Mix contained 33.6% citrus pulp, 19% soybean meal, 15.6% canola meal, 14% soybean hulls, 4.5%
calcium carbonate, 4.5% sodium bicarbonate, 2.8% urea, 2.7% fat, 2.4% sodium chloride, and <1% from
each of the following: Monocalcium phosphate, biotin, and Rumensin 90 (Elanco Animal Health,
Greenfield, IN).
3
Mix contained 43.6% Fermenten (Church and Dwight Co., Princeton, NJ), 21.8% calcium carbonate,
10.8% soybean hulls, 7.8% Mintrex blend (Novus International Inc., St. Charles, MO), 5.2% blood meal,
3.5% magnesium oxide, 2.6% Celmanax (Vi-COR, Mason City, IA), 2.6% Omnigen (Phibro Animal
Health Corp.), and <1% of each of the following: vitamin E, selenium selenite, and selenium yeast 600.
4
Mix contained 74.5% ground oats, 15.3% commercial amino acid, 8% Reashure (Balchem Encapsulates,
Slate Hill, NY), and <1% of each of the following: vitamin E and Niashure (Balchem Corporation, New
Hampton, NY).
5
Rumensin for dairy included at 4,890 mg/kg.
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Table 3-2. Insulin tolerance test (ITT) parameters for plasma glucose in lean and overweight
cows during late gestation and early lactation.1
Item
Basal glucose concentration (mg/dL)
-26
-13
+5
Minimum glucose concentration
(mg/dL)
-26
-13
+5
Maximum glucose concentration
(mg/dL)
-26
-13
+5
Glucose CR2 (%/10 min)
-26
-13
+5
Glucose CR (%/20 min)
-26
-13
+5
Glucose CR (%/30 min)
-26
-13
+5
Glucose CR (%/40 min)
-26
-13
+5
ISRG3 (mg/dL)
-26
-13
+5
Glucose AUC4 (mg 40 min/dL)
-26
-13
+5
Glucose AUC (mg 40 to 180 min/dL)
-26
-13
+5

BCS
Lean
Overweight

SEM

76.5
68.1
71.2

4.11
3.79
3.79

44.7
35.9
39.7

87.3
73.3
84.1
1.03
1.73
1.01
1.46
1.77
1.55
1.83
1.65
1.35
1.17
1.51
1.25
32.0
32.2
31.6
2163
1730
1952
9559
7580
8675

72.4
72.5
65.1

36.9
35.8
36.7

86.8
75.7
70.5
0.51
2.07
1.25
1.75
1.97
1.23
1.62
1.77
1.53
1.57
1.62
1.36
35.1
36.7
28.4
1930
1797
1800
8740
7652
6832

1
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0.36

0.55

0.70

0.53

0.12

0.35

0.97

0.23

0.78

0.88

0.52

0.74

0.91

0.55

0.79

0.21

0.39

0.71

0.62

0.41

0.51

0.54

0.28

0.66

0.20

0.09

0.40

3.36
3.08
3.08

4.82
4.45
4.45
0.49
0.45
0.43
0.32
0.30
0.29
0.22
0.20
0.20
0.15
0.14
0.13
2.72
2.52
2.52
136
125
125
557
512
512

Data represent ITT performed at d 26 and 13 prepartum, and d 5 postpartum.
CR = clearance rate.
3
ISRG = insulin-stimulated reductions in glucose.
4
AUC = area under the curve.
2

BCS
0.71

P-value
Period BCS × Period
0.48
0.53

Table 3-3. Glucose tolerance test (GTT) parameters for plasma glucose in lean and overweight
cows during late gestation and early lactation.1
Item
Basal glucose concentration (mg/dL)
-25
-12
+6
Minimum glucose concentration (mg/dL)

BCS
Lean
Overweight
70.5
77.2
65.5

71.4
77.2
56.7

SEM
4.55
4.26
4.41

-25
64.4
63.2
4.31
-12
68.1
63.7
3.97
+6
54.9
56.3
4.14
Maximum glucose concentration (mg/dL)
-25
276
285
16.2
-12
296
295
14.9
+6
251
240
15.6
Glucose CR2 (%/30 min)
-25
3.30
3.10
0.18
-12
2.55
2.52
0.16
+6
2.74
2.41
0.17
Glucose CR (%/60 min)
-25
2.33
2.32
0.12
-12
2.07
1.95
0.11
+6
2.34
1.96
0.12
T1/23 (min)
-25
31.1
30.2
2.15
-12
34.6
37.3
1.99
+6
31.1
36.4
2.07
Tbasal4 (min)
-25
110
110
3.92
-12
117
103
3.47
+6
101
116
3.61
Glucose AUC5 (mg 180 min/dL)
-25
17090
18110
948
-12
19938
18791
878
+6
16150
16168
915
1
Data represent GTT performed at d 25 and 12 prepartum, and d 6 postpartum.
2
CR = clearance rate.
3
T1/2 = time to reach half maximal glucose concentration.
4
Tbasal = time to reach basal glucose concentration.
5
AUC = area under the curve
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BCS
0.70

P-value
Period BCS × Period
0.01
0.57

0.79

0.15

0.86

0.96

0.07

0.89

0.35

0.02

0.82

0.24

0.19

0.53

0.34

0.21

0.58

0.89

0.93

0.02

0.97

0.06

0.64

Table 3-4. Glucose tolerance test (GTT) parameters for plasma FA in lean and overweight cows
during late gestation and early lactation.1
BCS
Overweight

Item
Lean
SEM
Basal FA concentration (mmol/L)
-25
179
244
1.19
-12
209
421
1.17
+6
501
1153
1.18
Minimum FA concentration (mmol/L)
-25
55.4
98.2
1.32
-12
39.6
143
1.30
+6
116
466
1.31
Maximum FA concentration (mmol/L)
-25
164
280
1.15
-12
232
467
1.13
+6
814
1435
1.14
FA CR2 (%/20 min)
-25
2.21
0.66
0.33
-12
2.29
1.25
0.32
+6
1.80
1.30
0.33
FA CR (%/40 min)
-25
2.39
1.63
0.24
-12
2.37
1.67
0.24
+6
2.37
1.67
0.24
T1/23 (min)
-25
47.1
50.0
4.89
-12
41.3
44.5
4.32
+6
36.0
52.8
4.67
GSRF (% from basal)4
-25
67.09
58.05
5.40
-12
72.90
65.47
5.01
+6
71.16
57.51
5.40
FA AUC5 (mmol 60 min/L)
-25
5651.88
10417
2439.77
-12
6420.43
15432
2194.77
+6
16729
41733
2406.49
FA AUC (mmol 90 min/L)
-25
7578.86
13988
3538.22
-12
8470.43
20037
3201.49
+6
24681
58406
3500.15
FA AUC (mmol 180 min/L)
-25
18422
31266
8653.79
-12
21718
47505
8011.85
+6
77427
158890
8653.79
1
Data represent GTT performed at d 25 and 12 prepartum, and d 6 postpartum.
2
CR = clearance rate.
3
T1/2 = time to reach half maximal glucose concentration.
4
GSRF = glucose-stimulated reductions in FA.
5
AUC = area under the curve
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BCS
0.001

P-value
Period BCS × Period
0.001
0.54

0.001

0.01

0.53

0.01

0.001

0.88

0.07

0.60

0.35

0.08

0.99

0.99

0.62

0.26

0.41

0.07

0.33

0.78

0.001

0.001

0.02

0.001

0.001

0.03

0.001

0.001

0.02

Table 3-5. Relationship between surrogate indices for insulin sensitivity1.
Item2
RQUICKI
HOMA-IR
QUICKI
RQUICKIBHBA

RQUICKI
ρ
P-value
1
-0.63
0.001
0.64
0.001
0.95
0.001

HOMA-IR
ρ
P-value
-0.63
0.001
1
-0.99
0.001
-0.49
0.01

QUICKI
ρ
P-value
0.64
0.001
-0.99
0.001
1
0.51
0.001

1

RQUICKIBHBA
ρ
P-value
0.95
0.001
-0.49
0.01
0.51
0.001
1

Data represent basal plasma samples collected in lean and overweight cows prior to intravenous glucose tolerance
tests at d 21 and 14 prepartum, and d 4 postpartum.
2
QUICKI = quantitative insulin sensitivity check, {1 / [log glucose (mg/dL) + log insulin (µU/mL)]}, RQUICKI =
revised QUICKI, {1 / [log glucose (mg/dL) + log insulin (µU/mL) + log FA (mmol/L)]}, RQUICKI BHBA =
RQUICKI including BHBA, {1 / [log glucose (mg/dL) + log insulin (µU/mL) + log FA (mmol/L) + log BHBA
(mmol/L)]}, and HOMA-IR = homeostasis model of insulin resistance, {[glucose (mmol/L) × insulin (µU/mL)] /
22.5}.
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Table 3-6. Comparison of tolerance testing glucose parameters and surrogate indices of insulin
sensitivity in peripartal dairy cows.1
Item
Insulin tolerance2
Glucose CR (%/10 min)3
Glucose CR (%/20 min)
Glucose CR (%/30 min)
Glucose CR (%/40 min)
ISRG4
Glucose AUC (mg 40 min/dL)

RQUICKI
ρ
P-value
0.38
0.14
0.24
-0.01
-0.01
-0.07

0.02
0.40
0.14
0.96
0.99
0.66

HOMA-IR
ρ
P-value
-0.26
0.03
-0.06
0.16
0.06
0.05

0.11
0.87
0.70
0.34
0.71
0.75

QUICKI
ρ
P-value
0.25
-0.03
0.03
-0.15
-0.07
-0.05

Glucose tolerance5
Glucose CR (%/30 min)
0.20
0.22
0.10
0.54
-0.12
Glucose CR (%/60 min)
0.16
0.32
0.03
0.82
-0.06
T1/2 (min)6
-0.16
0.33
-0.04
0.80
0.07
Tbasal (min)7
0.17
0.30
-0.12
0.47
0.11
8
Glucose AUC (mg 180 min/dL)
-0.01
0.94
0.18
0.26
-0.18
FA CR (%/10 min)
0.24
0.16
-0.32
0.05
0.32
FA CR (%/20 min)
0.31
0.06
-0.25
0.13
0.25
FA CR (%/30 min)
0.11
0.50
-0.12
0.46
0.12
FA CR (%/40 min)
0.12
0.47
-0.08
0.62
0.08
FA AUC (mg 20 min/dL)
-0.05
0.74
-0.38
0.02
0.38
FA AUC (mg 30 min/dL)
-0.06
0.73
-0.37
0.02
0.37
FA AUC (mg 40 min/dL)
-0.07
0.65
-0.34
0.04
0.34
1
Description of abbreviation can be found within table 1.
2
CR = clearance rate.
3
Data reflect samples collected at d 26 and 13 prepartum, and d 5 postpartum.
4
ISRG = insulin-stimulated reductions in glucose.
5
Data reflect samples collected at d 25 and 12 prepartum, and d 6 postpartum.
6
T1/2 = time to reach half maximal glucose concentration.
7
Tbasal = time to reach basal glucose concentration.
8
AUC = area under the curve.
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RQUICKIBHBA
ρ
P-value

0.12
0.86
0.83
0.36
0.66
0.74

0.32
0.08
0.16
-0.02
0.06
0.05

0.05
0.61
0.32
0.91
0.72
0.75

0.44
0.69
0.67
0.50
0.28
0.05
0.13
0.46
0.63
0.02
0.02
0.04

0.15
0.15
-0.14
0.17
-0.01
0.34
0.32
0.14
0.19
-0.11
-0.12
-0.14

0.34
0.35
0.37
0.29
0.96
0.05
0.05
0.38
0.26
0.49
0.46
0.41

CHAPTER 4
CHARACTERIZATION OF THE PLASMA LIPIDOME IN DAIRY CATTLE
TRANSITIONING FROM GESTATION TO LACTATION: IDENTIFYING NOVEL
BIOMARKERS OF METABOLIC IMPAIRMENT.

ABSTRACT
The discovery of novel biomarkers for metabolic disease can refine nutritional
interventions aimed at improving dairy cow health and performance. Therefore, our objective was
to characterize the plasma lipidome and identify metabolites associated with common markers of
metabolic disease in peripartal dairy cattle. Twenty-seven multiparous Holstein cows were
enrolled -28 d prepartum and fed diets formulated to meet or exceed requirements. Blood and liver
samples were routinely collected from enrollment through d 14 postpartum. To characterize the
plasma lipidome spanning nine time points, untargeted lipidomics was performed using
quadrupole time-of-flight mass spectrometry. Univariate and multivariate analyses of normalized,
auto-scaled lipidomic data were performed. Based on postpartum metabolic health data, cows were
categorized into low or high free fatty acid area under the curve (FFAAUC; d 1 – 14 postpartum;
4,915 ± 1,369 vs. 12,501 ± 2,761 [μmol/L × 14 d]; n = 18), β-hydroxybutyrate area under the curve
(BHBAAUC; d 1 – 14 postpartum; 4,583 ± 459 vs. 7901 ± 1,206 [μmol/L × 14 d]; n = 18), or mean
postpartum liver lipid content (d 5 and 14 postpartum; 5 ± 1 vs. 12 ± 2 % of wet weight; n = 18).
Significant variables associated with a specific category were identified based on leverage/squared
prediction error plots. Lipidomics revealed 301 plasma lipids including 8 cholesterol esters, 163
phospholipids, and 130 acylglycerols. Independent of category, all cows displayed dramatic
decreases in plasma triacylglycerols and monoalkyl-diacylglycerols (P < 0.01), and the majority
of phospholipids reached a nadir at parturition (P < 0.01). Analyses revealed that
phosphatidylcholine (PC) 32:3, 35:5, 37:5 were specific for high FFAAUC, PC 31:3, 32:3, 35:5, and
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37:5 were specific for high BHBAAUC, and PC 31:2, 31:3, and 32:3 were specific for high liver
lipid. Notably, PC 32:3 was specific for cows with elevated FFA, BHBA, and liver lipid content,
a metabolite that was lower in abundance relative to healthy cows (P < 0.01). Other lipids specific
for two or more categories included phosphatidylglycerol 38:4 and lysophosphatidylcholine 15:0.
Our lipidomics approach confirms dynamic remodeling of the bovine lipidome during the
peripartum. Future focus should be on nutritional interventions that increase plasma PC 32:3 in
cows during the peripartal period.
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INTRODUCTION
The prevalence of metabolic disease is high during the transition from gestation to
lactation, affecting on average 40% of the dairy cow population (LeBlanc, 2010). Metabolic
diseases develop because of the onset of negative energy balance caused by insufficient energy
intake and increased energy demand for lactation (Curtis et al., 1985). Postpartum metabolic
diseases in dairy cows include fatty liver, ketosis, mastitis, metritis, milk fever, and displaced
abomasum. The development of a metabolic disease can compromise milk production and
reproductive performance as well as cost associated with health management (Grӧhn et al., 1998;
Grӧhn et al., 1999; Duffield et al., 2009). Therefore, early detection or prevention of metabolic
disease has the potential to minimize disease onset and thus improve milk production, fertility, and
profitability (Saleem et al., 2012; Hailemariam et al., 2014; Kenéz et al., 2016). The advent of
lipidomics has the potential to improve our understanding of bovine lipid metabolism and reveal
novel biomarkers for metabolic disease which will refine nutritional interventions aimed at
improving dairy cattle health and performance.
At the present time, circulating free fatty acid (FA) and β-hydroxybutyrate (BHBA) are
industry standard biomarkers for metabolic impairment during the periparturient period.
Laboratory and cow-side tests have been developed to monitor circulating free FA and BHBA
levels, respectively. The alarm threshold levels for poor reproductive performance and milk
production for prepartum free FA and BHBA are 270 µmol/L and 550 µmol/L, respectively; and
postpartum free FA of 600 µmol/L (Ospina et al., 2010). The limitations for free FA and BHBA
testing are that (A) these metabolite thresholds represent the disease state (rather than pre-onset
disease which would be preferred), (B) free FA and BHBA monitoring ignores the interactions
between other causative metabolites of metabolic disease, (C) laboratory testing is expensive and
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requires additional labor, and (D) individual cow blood sampling is impractical. Therefore,
alternative biomarkers for postpartum metabolic disease are needed.
Lipidomics is a system biology approach that emerged in the field of life sciences to
investigate metabolite alterations in biological samples (Nicholson et al., 1999; Fischer, 2008;
Nam et al., 2015). The application of lipidomics to identify novel biomarkers of metabolic disease
in non-ruminants has been extensively employed (Barber et al., 2012; Donovan et al., 2013; Nam
et al., 2015). However, only a limited number of studies have employed this analytical technology
to better understand dairy cow health and performance (Hailemariam et al., 2014; Imhasly et al.,
2014; Sun et al., 2014; Imhasly et al., 2015; Rico et al., 2015). Initial work has identified several
phosphatidylcholines (PC) as biological indicators of postpartum metabolic disease (Hailemariam
et al., 2014). For instance, PC 30:2, 32:2, 36:2, 36:3, 36:4, 38:3, 38:4, 38:6, 40:2, 40:3, 40:4, and
42:2 can be used to distinguish between healthy cows or those with a varying clinical disease
(Imhasly et al., 2014). Phosphatidylcholine is a promising candidate because of the role it plays in
hepatic very low density lipoproteins (VLDL)-triacylglycerol synthesis and export (Agren et al.,
2005). However, a more comprehensive analysis of the bovine lipidome with multiple common
markers of metabolic disease has the potential to refine our current understanding. Applying high
throughput mass spectrometry-based technologies and bioinformatics can be employed
cooperatively to achieve this goal. Therefore, our objective was to employ this approach to
characterize the bovine plasma lipidome in Holstein dairy cows transitioning from gestation to
lactation, and relate these findings to circulating free FA, BHBA and liver lipid accumulation.
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MATERIALS AND METHODS
Experimental Design
Experimental procedures were approved by the Institutional Animal Care and Use
Committee at West Virginia University (Morgantown). The experiment was completed at Dovan
Farms, a West Virginia University Agricultural Research and Education Partner located in Berlin,
PA. Nonlactating, pregnant, multiparous Holstein cows (n = 27; parity 2 and 3) were enrolled 32
d prior to expected parturition, and offered a total mixed ration (TMR) to meet or exceed nutrient
requirements (Table 4-1). Cows were fed once (0800 h) and twice (0800 and 1900 h) daily during
pregnancy and lactation, respectively, and were provided free access to water. Cows were milked
twice daily at 0800 and 1800 h from d 1 to d 14 postpartum, then milked three times a day thereafter
(0500, 1400, and 2100 h).

Sample Collection
Blood collection (10 mL) by coccygeal venipuncture occurred prior to morning feeding on
d -28, -21, -14, daily from -7 to 7, 10, 12, 14, 21, and 28, relative to expected calving. Plasma
samples were placed on ice for 30 min, whereas serum samples were allowed to clot for 30 min at
room temperature until centrifugation at 3,400 × g for 10 min. Following centrifugation, plasma
and serum samples were removed and snap-frozen in liquid nitrogen, and then stored at -80oC until
further analysis. Samples of TMR were collected weekly throughout the experiment, and dry
matter content was determined by heating at 60oC until a static weight was observed. Body weight
(BW) and body condition score (BCS) were recorded weekly.
Liver tissue biopsies were performed prior to morning feeding on d -28, 5, and 14 d, relative
to expected calving. Cows were anesthetized using xylazine (0.04 mL/kg of BW) delivered via the
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coccygeal vein. After the hair was clipped, the biopsy site located within the 11th intercostal space
was scrubbed with iodine and anesthetized with 5 mL of 2% lidocaine HCL (Vedco Inc., Saint
Joseph, MO) delivered subcutaneously. A 0.5 cm incision was made through the skin and
fabricated trocar (Hughes, 1962) was inserted to collect approximately 1 g of liver tissue. Liver
samples were immediately snap-frozen in liquid nitrogen and stored at -80oC. Following biopsy,
the collection site was stapled and sprayed with antiseptic, and ceftiofur hydrochloride antibiotic
was administered once by intramuscular site (0.68 mL/kg of BW; Excenel RTU; Zoetis, Florham
Park, NJ).

Sample Analyses
Nutrient composition of TMR was analyzed using near-infrared spectroscopy (AOAC
method 989.03) by Cumberland Valley Analytical Services Inc. Plasma samples were analyzed in
duplicate for free FA, glucose, and BHBA by commercial kits using enzymatic methods (HR series
FA-HR (2), Autokit Glucose, Autokit 3-HB, respectively; Wako chemicals USA Inc., Richmond,
VA). Plasma concentrations of insulin were determined by ELISA (Mercodia Bovine Insulin
ELISA; Mercodia AB, Uppsala, Sweden). Spectrophotometric measurements were conducted
using a SpectraMax Plus 384 Microplate Reader (Molecular Devices, Sunnyvale, CA). Total liver
lipid content was determined using method described by Hara and Radin (1978), and Piepenbrink
and Overton (2003).
For lipidomics, plasma samples were extracted using a modified Bligh and Dyer procedure
to obtain a crude lipid fraction. In brief, 60 l of plasma was gently mixed in a glass vial with 940
ml ddH2O and 2.9 mL methanol/dichloromethane (2:0.9, v/v) containing the following internal
standards: N-lauroyl-D-erythro-sphingosine (Cer d18:1/12:0, 6 ng/mL), 1,3(d5)-dihexadecanoyl-

69

glycerol (d5-DAG d16:0/16:0, 12.5 ng/mL), D-galactosyl-β-1,1' N-lauroyl-D-erythro-sphingosine
(GlcCer d18:1/12:0, 3.3 ng/mL), D-lactosyl-β-1,1' N-lauroyl-D-erythro-sphingosine (LacCer
18:1/12:0,

10.6

ng/mL),

1,3(d5)-dihexadecanoyl-2-octadecanoyl-glycerol

(D-5

TAG

16:0/18:0/16:0, 0.5 ng/mL), cholesteryl-d7 palmitate (cholesteryl-d7 ester 16:0, 30 ng/mL), 1,2dilauroyl-sn-glycero-3-phosphate (sodium salt) (PA d12:0/12:0, 1025 ng/mL), 1,2-dilauroyl-snglycero-3-phosphocholine

(PC

12:0/12:0,

0.2

ng/mL),

1,2-dilauroyl-sn-glycero-3-

phosphoethanolamine (PE d12:0/12:0, 1.6 ng/mL), 1,2-dilauroyl-sn-glycero-3-phospho-[1'-racglycerol] (PG d12:0/12:0, 200 ng/mL), 1,2-dilauroyl-sn-glycero-3-phospho-L-serine (PS
d12:0/12:0), N-lauroyl-D-erythro-sphingosylphosphorylcholine (SM d18:1/12:0, 0.3 ng/mL), all
internal standards were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL). To obtain a
biphasic mixture, an additional 1mL of ddH2O and 0.9 mL dichloromethane was added and
vortexed. The resultant mixture was incubated on ice for 30 min and centrifuged (10 min, 3000 g,
4oC) to separate the organic and aqueous phases. The organic phase was removed and stored at 20oC. Just prior to analysis 1 mL of the organic layer was dried using a nitrogen evaporator
(Organomation Associates, Inc., Berlin, MA, USA) and re-suspended in 250 µl of running solvent
(dichloromethane:methanol (1:1) containing 5 mM ammonium acetate), and 5 mg/mL of ceramide
C17:0 used to track instrument performance. All solvents used were HPLC grade.
Lipid analysis was conducted by MS/MSALL on a TripleTOFTM 5600 (AB SCIEX,
Redwood City, CA) mass spectrometer. Samples (50 L injection volume) were infused by HPLC
at a constant flow rate of 5 µL/min using a LC-20AD pump, and SIL-20AC XR autosampler
(Shimazu, Canby, OR). Source parameters were as follows: ion source gases 15 psi (GSI) and 20
psi (GS2), curtain gas 30 psi, temperature 150oC, positive ion spray voltage +5500V, declustering
potential at 80 V and collision energy at 10V. Each sample was run in duplicate in positive ion
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mode. An initial TOF MS scan provided an overview of the total lipid content at an accumulation
time of 5 s. Precursor ions were selected by sequential 1 Da mass steps from 200 to 1200 m/z, and
the analytes in each 1Da step were introduced into the collision chamber and fragments identified
by TOF with a scan range of 100-1500 m/z and accumulation time of 450 ms. TOF MS and
MS/MSALL data obtained was post-aligned to internal standards using Analyst 1.7 TF.
Lipid identifications were validated using a pooled sample that was extracted and
sequentially analyzed 8 times. Criteria for inclusion of lipid analytes for analysis was that MS/MS
fragment peaks were present in 7 of the 8 pooled runs, and coefficient of variation (CV) for peak
identifications were less than 20 %. Peak identifications meeting these criteria were then used to
develop a targeted method in LipidView. The targeted method was used to identify these prevalidated lipid species in experimental samples using a custom made MatLab script and
MultiQuant software (version 3.0, AB SCIEX, Concord, ON, Canada). All peak intensities were
corrected by their corresponding internal standard, and each sample duplicate was averaged. If
duplicates varied more than 30%, the sample was re-run. For statistical analyses, intensity values
of 0 were replaced with a minimum intensity value that was calculated by dividing the average
intensity value of for that particular lipid by 0.001.

Statistical Analyses
Changes in BW and BCS were analyzed under the GLM procedure of SAS (version 9.3;
SAS Institute Inc., Carry, NC). Plasma variables and liver lipid percent were analyzed as repeated
measures over time relative to parturition under the MIXED procedure of SAS (SAS Institute Inc.).
The statistical model included the random effect of cow, and the fixed effect of time (day relative
to parturition). The most appropriate covariance structure for the repeated measures analysis was
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selected for each variable after evaluating 3 different covariance structures (variance components,
first-order autoregressive, compound symmetry), and the structure with the smallest Akaike’s
information criterion coefficient was selected for analysis. The method of Kenward-Rogers was
used for calculation of denominator degrees of freedom. In order to reduce risk of type I error for
repeated measures analysis, the significance level was decreased to P ≤ 0.05, and trends toward
significance were considered at 0.05 < P ≤ 0.10. Studentized residual values >3.0 or <-3.0 were
considered outliers and removed from the analysis (typically 1 per response variable). All related
results are expressed as least squares means and their standard errors, unless stated otherwise.
Lipidomic data were analyzed using MetaboAnalyst (Xia et al., 2016). Log transformation
and autoscaling were employed for normalization of all lipidomic data, followed by visual
inspection of normal distribution. To perform longitudinal analysis, we analyzed time-dependent
metabolite changes over an 8-wk period. Multivariate analysis of normalized, auto-scaled
lipidomic data included random forest (RF) classification, partial least squares discriminant
analysis (PLS-DA), ANOVA, and Pearson’s correlation coefficient procedures. Based on
postpartum metabolic health data, cows were separately categorized into low or high free FA area
under the curve (FFAAUC), BHBA area under the curve (BHBAAUC), or mean postpartum liver
lipid content. Significant variables associated with a specific category were identified based on
leverage/squared prediction error plots.

RESULTS
Metabolic Health Status
The transition from gestation to lactation was accompanied by suppressed DMI (Figure 41A; P < 0.01), as well as BW and BCS loss (Figure 1B and C; P < 0.01). Characteristic
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observations indicative of metabolic stress were detected. Specifically, plasma free FA and BHBA
levels, and liver lipid content were elevated postpartum (Figure 4-1D, E, and F; P < 0.01), while
plasma insulin and glucose levels were expectedly lower following parturition (Figure 4-1G, and
H; P < 0.01).

Plasma Lipidome Remodeling during the Peripartum
HPLC/TOF MS data were loaded for PLS-DA analyses to investigate the global lipidome
of plasma samples from multiparous Holstein dairy cows during the transition period. The
lipidomic approach revealed 301 plasma lipids including 163 phospholipids (phosphatidylcholine
(PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylglycerol (PG),
lysophosphatidylcholine (LPC), lysophosphatidylethanolamine (LPE), lysophosphatidylserine
(LPS)), 130 fatty acylglycerols (triacylglycerol (TAG), diacylglycerol (DAG), and monoalkyldiacylglycerol (MADAG)) and 8 cholesteryl esters (CE). A two-dimensional PLS-DA model was
applied to identify a subset of variables that distinguishes between time points (d -28 to d 14,
relative to parturition) and a variable importance of projection (VIP) score of > 1 based on
Component 1 (explained 40 % of variables) of the PLS-DA model was used to determine the
relative contribution of lipid species to discriminate between time points (Figure 4-2). PLS-DA
(Figure 4-2A) score plots illustrate a significant separation across all time points. Variance for
Component 1 was explained by dynamic changes in TAG, MADAG, PS, and LPS (Figure 4-2B).
Additionally, a dominant lipid pattern showing a reduction of TAG 60:1, 62:0, 56:1, 60:0, 56:0,
62:1, 58:0, 58:1, 58:2, and 56:4; MADAG 58:1, 60:1, 60:2, 62:1, 56:4, 60:0, 54:5, 52:1, 48:0, 52:0,
58:0, and 50:0; PS 28:0; and LPS 30:6 postpartum. These changes reflected total plasma TAG and
MADAG, LPS, PS levels which consistently declined during the transition from gestation to

73

lactation (Figure 4-4 and 4-5; P < 0.01); while total PC and PE levels increased postpartum. The
majority of phospholipids such as LPC, PC, LPE, and PE reached a nadir at parturition (P < 0.01).
Component 2 (explained 19% of the variance; Figure 4-2C) was explained by reduction in TAG,
MADAG, PS, and LPS; meanwhile increase in LPE 18:2, PC 34:2, LPC 18:2, and DAG 38:3
during the peripartum period. Specifically, component 2 included reductions in TAG 60:1, 62:0,
56:1, 56:0, 60:0, 62:1, 58:0, and 58:1; MADAG 60:1, 60:2, 52:2, 56:4, 62:2, 60:0, 54:5, 50:1, 48:0,
and 52:0; PS 28:0; and LPS 30:6.
Random forest analysis was developed by Breiman (2001) and has since been used as a
supervised statistical tool in clinical metabolomics and gene selection studies (Díaz-Uriarte et al.,
2006; Chen et al., 2013). It is an excellent classification method that provide measures for
metabolite selection by identifying key metabolites that discriminate between time points during
the transition period. The main advantage of this model is to retrieve very small sets of metabolites
that possess a high predictive accuracy, thus can be an ideal method for metabolite characterization
and classification. Random forest (Figure 4-3A) is used to predict classes of metabolites based on
days and is based on bootstrap sampling (e.g. take random samples from original data set with
replacement), thus some data are left out of the bootstrap sample, which are called out-of-bag
(OOB). The OOB data is then used as a test sample to predict the classification error rate.
Therefore, the mean decrease in accuracy (Figure 4-3B) is calculated based on prediction of the
OOB data set. Figure 3B shows important metabolites that differentiate between time points. As
cows approached parturition, TAG 38:2 and 58:1, LPS 30:6, and MADAG 58:1, 46:0, 54:1, and
60:7 declined and remained low until day 14, whereas DAG 38:3, LPE 18:2, LPC 16:0 and 18:2,
PG 36:2, and PC 36:2 and 34:2 increased after parturition.
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Prepartum data was isolated, and two-dimensional PLS-DA model was used to identify a
subset of variables that distinguishes between prepartum time points (Figure 4-6A). Plasma lipids
LPS, TAG, LPC, and MADAG decreased as parturition approached. Prepartum variance for
Component 1 is explained by changes in LPS, TAG, LPC, and MADAG. A heat map shows
reduction in LPS 30:6, TAG 38:2, 54:0, 56:1, 54:1, 56:2, 56:3, 56:0, and 56:6, LPC 18:0, 15:0,
20:4, and 20:3, and MADAG 54:1, 52:0, 62:1, 60:2, 60:0, 54:7, 52:1, 56:3, and 54:0 prepartum
(Figure 4-6C).
Postpartum data was isolated, and two-dimensional PLS-DA model was used to identify
metabolites that distinguishes between postpartum time points (Figure 4-6B). Plasma PC, LPC,
PG, LPE, PE, and DAG increased postpartum. Postpartum variance for Component 1 is explained
by changes in PC, LPC, PG, LPE, PE, and DAG. A heat map shows increases in PC 34:2, 36:2,
36:3, 35:2, 33:2, 35:3, 36:4, 33:3, 36:1, and 34:3, LPC 18:2, 16:0, 18:0, 18:1, 28:3, 30:3, 28:2,
16:1, and 30:4, PG 38:5, LPE 18:2, PE 34:2, 36:2, and 26:4, and DAG 38:3 postpartum (Figure 46D).

Correlations of PC and TAG Species
Because of the characterized relationship between hepatic PC synthesis and VLDL-TAG
export (Li and Vance, 2008), we explored the relationship between circulating PC and TAG using
Pearson’s correlation coefficient analysis (Figure 4-7). A heat map (r-values) demonstrates that 69
PC (C24-C42) were correlated with 49 TAG (C38-C64). Our results illustrate that the plasma
levels of PC species were positively or negatively correlated with the plasma levels of TAG,
depending on fatty acyl chain length of PC species.
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Identification of Biomarkers Associated with Metabolic Stress
Based on postpartum metabolic health status, cows were categorized into low or high free
FFAAUC (d 1-14 pp; 4,915 ± 1,369 vs. 12,501 ± 2,761 [µmol/L × 14 d]), BHBA AUC (d 1-14 pp;
4,583 ± 459 vs. 7,901 ± 1,206 [µmol/L × 14 d]), or mean liver lipid deposition (d 5 and 14 pp; 5 ±
1 vs. 12 ± 2 % of wet weight, respectively). Significant variables associated with a specific
category were identified based on leverage/squared prediction error plots (Figure 4-8). Our
analyses revealed that PC 36:6, 32:3, 34:4, 32:2, 31:3, 34:6, 33:5, 31:2, 37:6, 38:2, 40:5, 38:3,
35:6, 37:0, and PE 34:4 and 34:3 were specific for high liver lipid content, PC 32:3, 35:2, 38:1,
35:5, 33:1, 37:2, 37:0, 35:0, 33:0, 37:5, 33:2, 36:4, 39:2, PE 39:0 and 45:4, LPC 30:2 and 30:1,
TAG 46:2, and PG 38:4 were specific for high FFAAUC, whereas PG 36:4, 39:0, 38:4, 38:6, PC
37:5, 32:3, 35:5, 32:0, 31:3, 32:4, 30:2, DAG 40:4, 36:0, 30:2, LPC 22:5, 15:0, 18:0, and PE 37:6
and 34:3 were specific for high BHBAAUC (Figure 4-8). Notably, PC 32:3 was specific for high
FFAAUC, BHBAAUC, and liver lipid cows.

DISCUSSION
The transition from gestation to lactation is defined as three weeks before to three weeks
after parturition, which imposes a metabolic risk in dairy cow (Grummer, 1995; Drackley, 1999).
It is well documented that the development of metabolic diseases are associated with suppressed
feed intake and increased energy requirements for lactation (Curtis et al., 1985). In particular,
dysfunctional lipid metabolism is associated with diverse metabolic disorders in Holstein dairy
cows (Drackley, 1999). Thus, better understanding of bovine lipid metabolism is crucial to
improve animal health and productivity. In our study, we utilized lipidomics approach to profile
the plasma lipidome of multiparous dairy cow transitioning from gestation to lactation to shed light
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on our understanding of metabolic disease and work towards identifying novel targets for future
nutritional intervention aimed at improving dairy cow health and performance.
In our study, the dramatic loss of BW and BCS were accompanied by suppressed DMI and
elevated free FA and BHBA, responses that have been previously observed in periparturient dairy
cows (Roche et al., 2009), reflecting a metabolic adaptation associated with the onset of lactation
in dairy cows (Reid et al., 1986). Adaptations in nutrient metabolism ensure energy supply to the
fetus and neonate (Bauman and Currie, 1980). However, maternal adaptations accelerate lipolysis
and predispose dairy cow to enhanced risk for developing a postpartum metabolic disorders.
Insulin resistance is a common physiological response during the transition from late gestation to
early lactation, which promotes adipose tissue lipolysis and enhances metabolic disease (Rico, et
al., 2015; Rico et al, 2016). Previously, our lab utilized a targeted lipidomic approach to reveal
sphingolipid ceramide as a plasma and skeletal muscle biomarker of insulin resistance (Rico et al.,
2016). In the present study, we utilized an untargeted lipidomics approach to (1) identify other
potential biomarkers of metabolic disease and (2) improve our understanding of phospholipid and
acylglycerol metabolism in relation to metabolic health.
PLS-DA score plots demonstrated clear separation of plasma metabolites between time
points. As cows approach parturition, neutral lipids such as TAG and MADAG declined and
remained low postpartum. Levels of TAG, MADAG, LPC, and PC differed significantly pre- and
postpartum, indicating dynamic changes of lipids during peripartum. Additionally, RF was used
as an alternative classification model. Similarly, results demonstrate reduction of TAG and
MADAG, meanwhile increase of PC and LPC species postpartum. To consolidate our
understanding, we applied PLS-DA pre- and postpartum, separately. VIP scores result for
Component 1 was comparable to our previous results, which indicates reduced plasma levels of
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TAG and higher content of PC and LPC. Comparable to our study, PC 34:2 and 36:2 were
recognized as the most contributing metabolites to distinguish between pre- and postpartum in
dairy cow (Kenéz et al., 2016). In a non-ruminant study, lipidomic analysis revealed significant
elevation of ether-linked PC and PE in plasma of an obese individual (Donovan et al., 2013). These
specific results suggest that low levels of plasma PC and LPC are associated with improved cow
health. However, a challenging question is whether all PC species are associated with metabolic
disease or rather a subclasses of them.
In biological systems, PC comprises majority of plasma VLDL components following PE
and LPC (Agren et al., 2005). Phosphatidylcholine is the main form of choline phospholipids and
reduced hepatic PC levels impair VLDL export (Zeisel, 1992; Verkade et al., 1993; Fast and
Vance, 1995), thus, elevate the accumulation of TAG in the liver (Bobe et al., 2004). Ruminants
in particular, have an inherently low capacity to remove TAG from the liver in the form of VLDL
(Kleppe et al., 1988; Pullen et al., 1990), and excessive hepatic free FA uptake can lead to TAG
accumulation, and increase the incidence of fatty liver disease and ketosis, which further can lead
to serious metabolic disorders, such as mastitis, metritis, and milk fever (Herdt, 2000; Bobe et al.,
2004). Phosphatidylethanolamine may be as well required for VLDL assembly, particularly
nascent VLDL contain more PE than plasma VLDL (Hamilton and Felding, 1989). Unfortunately,
the requirement of PC and PE for VLDL assembly has not been defined for dairy cows. However,
phospholipids have been recognized as potentially important metabolites for VLDL assembly and
secretion (Van de Top et al., 1996; Kessler et al., 2014). Therefore, to facilitate VLDL export, PC
and PE are likely needed. Noticeably, despite higher levels of PC and PE later in early lactation,
plasma TAG remained low. Possible explanation might be that origin of PC extract from plasma
is uncertain, and expected changes in circulating PC likely depend on acyl chain moiety.
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One should consider the diverse structure of TAG, degree of saturation, and their
contribution on VLDL assembly and secretion. Therefore, we investigated the pattern of TAG
saturation during the peripartum period. Levels of saturated and monounsaturated TAG were
negatively correlated with the progress of the peripartum period. As cows progress through
lactation mono- and polyunsaturated TAG (e.g. TAG 60:1, 58:2) and saturated TAG (e.g. TAG
60:0) are reduced. This reflects the hepatic accumulation of TAG, thus progression of fatty liver
disease. Of note, the present study indicates that the PC acyl moiety in the plasma is associated
with levels of plasma TAG. The acyl chain length correlation between PC and TAG species can
be either positive or negative. In a previous studies, the PC levels were shown to be elevated in
periparturient dairy cows, which indicates the abnormal lipid metabolism (Hailemariam et al.,
2014; Kenéz et al., 2016). In particular, our results are comparable to Imhasly et al. (2015) which
reported reduced TAG species with different chain length and levels of saturation, meanwhile
increased PC species postpartum. Thus, one can postulate that PC acyl moiety may influence TAG
export. Further, to clearly elucidate the association of PC species with TAG species, liver
exploration is warranted.
Our lipidomic investigation revealed a novel lipid class not yet considered in dairy science,
MADAG. Monoalkyl-diacylglycerol are neutral lipids that aggregate within hepatic lipid droplets
with TAG (Bartz et al., 2007). Our results suggest that the hepatic transport of MADAG and TAG
may share a similar pathway. Further, a similar pattern of TAG remodeling was observed for
saturated and unsaturated MADAG. Unfortunately, the relative contribution of MADAG as a
modulators of energy metabolism and VLDL secretion in ruminants and monogastrics are
unknown. Thus, future studies should characterize the role of MADAG in VLDL assembly and
their association with metabolic disease.
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Excessive hepatic free FA during the peripartum period can be re-esterified to form other
neutral lipids (i.e., DAG, and CE) or glycerophospholipids (i.e., LPC, PS, LPG, and PG). Several
studies have shown the relative contributions of DAG and LPC in obesity and diabetic nonruminants (Erion and Shulman, 2010; Barber et al., 2012). For instance, LPC 16:0 was identified
as the key metabolite in fatty liver-induced insulin resistance in humans (Lehmann et al., 2013).
Additionally, it has been speculated that DAG is a potential biomarker of insulin resistance in
humans (Erion and Shulman, 2010). Specifically, DAG 18:1, 18:2, and 20:4 were shown to be
positively associated with acute muscle insulin resistance in humans (Szendroedi et al., 2013). In
our study, levels of total DAG increased after parturition that developed in parallel with elevated
insulin resistance in early lactation dairy cow. However, more investigation is needed in dairy
cows to unravel the role of DAG species on insulin sensitivity during the periparturient period.
Additionally, we analyzed the association of PC species with common biomarkers of
metabolic impairment during the peripartum period. The circulating free FA and BHBA are
diagnostic biomarkers of the active disease state and poor performance (Ospina et al., 2010; Ospina
et al., 2010). However, they are not an ideal predictive biomarkers (reflect disease state) for
metabolic disease during the transition period. Thus, evaluating PC species as potential predictive
biomarkers of metabolic disease are warranted. The relative concentrations of several PC species
were suppressed with increased postpartum liver lipid content (component of fatty liver disease),
high free FA and BHBA. Therefore, one may assume that not all PC species contribute in similar
manner to VLDL assembly. In particular, PC 32:3 was reduced in all aforementioned categories,
which indicates the possible importance of this metabolite in VLDL assembly, thus improving cow
health.
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In conclusion, the plasma samples of multiparous Holstein dairy cow model were
characterized using HPLC/QTOF MS-based lipid profiling to enhance understanding of lipid
metabolism during transition from gestation to lactation. Our lipidomic approach identified the
importance of PC 32:3 as a potential biomarker of metabolic disease. Future studies should
determine the prognostic and diagnostic efficacy of PC 32:3 to monitor disease progression.
Moreover, the development of nutrition interventions that increase PC 32:3 may be beneficial.
Finally, the structural and functional role of MADAG should be considered in content of hepatic
VLDL export.
1
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Figure 4-1. Dry matter intake (DMI) suppresses as cow approaches parturition, and body weight
(BW) and body condition score (BCS) decline postpartum. Circulating free fatty acid (FA) and βhydroxybutyrate (BHBA), and liver lipid content are elevated postpartum. Insulin and glucose
concentrations decrease postpartum. (A) DMI, (B) BW, (C) BCS, (D) FA, (E) BHBA, (F) hepatic
lipid deposition, (G) insulin, and (H) glucose. Data are represented as least squares means and their
standard errors.
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Figure 4-2. Plasma neutral lipids triacylglycerol (TAG) and monoalkyl-diacylglycerol (MADAG)
decrease dramatically during the peripartum. (A) Two-dimensional partial least squares
discriminant (PLS-DA) score plot, (B) VIP scores analysis based on Component 1 of the PLS-DA,
and (C) VIP scores analysis based on Component 2 of the PLS-DA used to rank the relative
contribution of metabolites to the variance between time points. Variance for Component 1 is
explained by changes in TAG, MADAG, phosphatidylserine (PS), and lysophosphatidylserine
(LPS). Normalized, auto-scaled data is representative of plasma collected from multiparous
Holstein dairy cows (n= 27) prior to morning feeding at nine time points spanning the peripartum
(d-28 to d14). PLS-DA score plots demonstrate good fitness and high predictability of model with
R2 and Q2 values ≥ 0.73 and 0.85, respectively. Data were obtained using quadrupole time-of-flight
mass spectrometry.
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Figure 4-3. Random Forest analysis revealed that subjects are distinguishable across nine time
points (class error = 0.15). Permutation importance reveals significant metabolites identified by
Random Forest method. The metabolites are ranked by the mean decrease in classification
accuracy when they permuted. Each lines represent the error rates for each day. (A) Random
Forest, (B) permutation importance. Data were obtained using quadrupole time-of-flight mass
spectrometry.
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Figure 4-4. Circulating total triacylglycerol (TAG) and neutral ether lipid monoalkyldiacylglycerol (MADAG) decreased postpartum. Circulating phospholipid concentrations are
lowest at parturition in periparturient Holstein dairy cows. Normalized, auto-scaled data reflect the
sum of (B) 49 TAG (C38-C64), (C) 64 MADAG (C40-C62), (D) 29 lysophosphatidylcholine
(LPC; C14-C30), (E) 69 phosphatidylcholine (PC; C24-C42), (F) 5 lysophosphatidylethanolamine
(LPE; C18-C26), and (G) 38 phosphatidylethanolamine (PE; C26-C45) species measured in
plasma collected from multiparous Holstein dairy cows (n = 27) at nine time points spanning the
peripartum (d -28 to d 14). Data were obtained using quadrupole time-of-flight mass spectrometry.
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Figure 4-5. Circulating cholesterol esters (CE), diacylglycerol (DAG), and phosphatidylglycerol
(PG) decrease as cow approaches parturition, circulating lysophosphatidylserine (LPS), and
phosphatidylserine (PS) decrease postpartum, and lysophosphatidylglycerol (LPG) remains
unchanged during the peripartum. Data were obtained using quadrupole time-of-flight mass
spectrometry.
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Figure 4-6. Plasma lipids lysophosphatidylserine (LPS) and triacylglycerol (TAG) prepartum and
phosphatidylcholine (PC) and lysophosphatidylcholine (LPC) postpartum decrease drastically.
(A) Two-dimensional partial least squares discriminant (PLS-DA) score plot prepartum, (B) Twodimensional PLS-DA score plot postpartum, (C) VIP scores analysis based on Component 1 of the
PLS-DA prepartum, (D) VIP scores analysis based on Component 1 of the PLS-DA postpartum,
(E) VIP scores analysis based on Component 2 of the PLS-DA prepartum, and (F) VIP scores
analysis based on Component 2 of the PLS-DA postpartum used to rank the relative contribution
of metabolites to the variance between time points. Prepartum variance for Component 1 is
explained by changes in LPS, TAG, LPC, and monoalkyl-diacylglycerol (MADAG). Postpartum
variance for Component 1 is explained by changes in PC, LPC, phosphatidylglycerol (PG),
lysophosphatidylethanolamine (LPE), phosphatidylethanolamine (PE), and diacylglycerol (DAG).
Normalized, auto-scaled data is representative of plasma collected from multiparous Holstein dairy
cows (n= 27) prior to morning feeding at four time points spanning the prepartum and five time
points spanning the postpartum. Data were obtained using quadrupole time-of-flight mass
spectrometry.
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Figure 4-7. Depending on fatty acyl moiety, plasma phosphatidylcholine (PC) levels are positively
or negatively correlated with circulating triacylglycerol (TAG). Pearson’s correlation coefficient
analysis represents normalized, auto-scaled data collected from plasma of periparturient Holstein
dairy cows (n = 27) at nine time points spanning the peripartum (d -28 to d 14). Heat map is
representative of r-values. Data were obtained using quadrupole time-of-flight mass spectrometry.
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Figure 4-8. Suppressed plasma phosphatidylcholine (PC) levels are associated with fatty liver
disease, high free FA, and BHBA area under the curve (AUC) concentrations in periparturient
Holstein dairy cows. Leverage/squared prediction error (SPE) plot of 301 complex lipid and their
relationship with (A) hepatic lipid accumulation, (B) elevated FFAAUC concentrations, and (C)
elevated BHBAAUC concentrations. Normalized, auto-scaled data represent data collected from
periparturient Holstein dairy cows categorized into low (n = 9) or high (n = 9) mean (d 5 and 14
postpartum) liver lipid content (5 ± 1 vs. 12 ± 2 % of wet weight, respectively), low (n =9) or high
(n = 9) FFAAUC (d1-14 postpartum; 4,915 ± 1,369 vs. 12,501 ± 2,761 [µmol/L × 14 d]), and low
(n = 9) or high (n = 9) BHBAAUC (d1-14 postpartum; 4,583 ± 459 vs. 7,901 ± 1,206 [µmol/L × 14
d]). Metabolites in red area have high loadings and follow the expression pattern of the submodel
(i.e. data demonstrate that out of 301 metabolites, the suppression of specific PC levels are most
associated with fatty liver disease). Data were obtained using quadrupole time-of-flight mass
spectrometry. PE = Phosphatidylethanolamine
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Table 4-1. Ingredients and nutrient composition of diets fed to dairy cows during the transition
from late gestation to early lactation.
Diets
Ingredients, % of DM

Prepartum

Postpartum

Corn Silage
35.89
43.06
Grass Haylage
27.26
6.41
Grass Hay
14.7
3.13
1
Concentrate Mix A
16.14
Ground Corn
15.74
2
Concentrate Mix B
14.33
Soybean Meal
7.82
6.14
Cottonseed
4.47
3
Concentrate Mix B
4.31
Palmit Fat
0.5
Rumensin
0.1
Nutrient, % of DM
Dry matter (% as-fed)
45.73
49.08
Crude Protein
15.38
16.57
Neutral detergent fiber
47.74
35.42
Acid detergent fiber
29.65
21.65
Non fiber carbohydrate
27.45
39
Ash
8.82
7.24
1
Mix contained 28.0% citrus pulp, 30.3% soybean meal 47.5%, 18.7% distillers, 9.3% soy hulls,
3.3% calcium carbonate, 3.7% sodium bicarbonate, 2.3% urea, 2.3% fat, 2.1% salt, 0.3% biotin
640.
2
Mix contained 24.9% soybean meal 47.5%, 23.2% ground corn, 16.6% corn distillers, 12,4%
animate, 10.4% calcium carbonate, 9.1% selenium yeast, 2.5% calcium sulfate, and < 1% of each
of the following: biophos, selenium yeast, and Vitamin E.
3
Mix contained 43.6% fermenten, 21.8% calcium carbonate, 13.5% soybean hulls, 7.8% 1965 mill
mix 4 mintrex, 5.2% blood meal, 3.5% magnesium oxide, 2.6% celmanax, and <1% of each of the
following: Vitamin E, selenium 0.06%, and 9273 selenium yeast 600.
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CHAPTER 5
GENERAL CONCLUSIONS
In the first experiment presented, our primary objective was to evaluate the effect of
prepartum adiposity on systemic glucose and insulin tolerance test in lean and overweight dairy
cattle during the transition period. Our second objective was to investigate the relationship between
direct and indirect measurements of insulin sensitivity in the periparturient period. Our results
demonstrate minimal effect of prepartum adiposity on glucose and insulin tolerance test
parameters, except lower glucose-stimulated reductions of FA following a glucose challenge in
overweight dairy cows. Additionally, we observed a poor correlation between surrogate indices
and direct measurements of insulin sensitivity which questions the usefulness of indirect
measurements of insulin sensitivity during the periparturient period in dairy cattle.
In the second experiment, we characterized the plasma lipidome and identified potential
biomarkers associated with common biomarkers of metabolic disorder in the transition dairy cattle
using mass spectrometry-based lipidomics and bioinformatics. Our results revealed 301 plasma
lipids including phospholipids, acylglycerols, and cholesterol esters. Further, we identified that PC
32:3 was specific for cows with elevated FFA, BHBA, and liver lipid deposit. Collectively, our
lipidomics approach demonstrates the dynamic remodeling of the plasma lipidome during the
transition period. Future research should be focus on validation of these metabolites and possible
nutritional intervention to modify them toward improve animal health and performance.
In summary, prepartum adiposity does not modify postpartum systemic insulin sensitivity,
and surrogate indices for insulin sensitivity are not associated with direct measurements of insulin
sensitivity. Moreover, we identified potential biomarkers of metabolic disease during the transition
period including PC 32:3.
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